
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | (Registrant’s telephone number, including area code) | |||||||||||||||||||||
(Address of principal executive offices, including Zip Code) | |||||||||||||||||||||||
Securities registered pursuant to Section 12(b) of the Act: | ||||||||
| Title of each class | Trading Symbol(s) | Name of exchange on which registered | ||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.875% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.250% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 6.500% | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||||||||||||||||||||||
| Table of Contents | Part | Item | Page | |||||||||||
| I | ||||||||||||||
| I | 2 | |||||||||||||
| I | 3 | |||||||||||||
| I | 1 | |||||||||||||
| I | 4 | |||||||||||||
| II | ||||||||||||||
| II | 1 | |||||||||||||
| II | 1A | |||||||||||||
| II | 2 | |||||||||||||
| II | 5 | |||||||||||||
| II | 6 | |||||||||||||
2 | ||||||||
3 | ||||||||
4 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||




| March 2024 Form 10-Q | 5 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||



6 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
$ in millions, except per share data | 2024 | 2023 | ||||||
| Consolidated results | ||||||||
| Net revenues | $ | 15,136 | $ | 14,517 | ||||
| Earnings applicable to Morgan Stanley common shareholders | $ | 3,266 | $ | 2,836 | ||||
| Earnings per diluted common share | $ | 2.02 | $ | 1.70 | ||||
| Consolidated financial measures | ||||||||
Expense efficiency ratio1 | 71 | % | 72 | % | ||||
ROE2 | 14.5 | % | 12.4 | % | ||||
ROTCE2, 3 | 19.7 | % | 16.9 | % | ||||
Pre-tax margin4 | 29 | % | 26 | % | ||||
| Effective tax rate | 21.2 | % | 19.3 | % | ||||
Pre-tax margin by segment4 | ||||||||
| Institutional Securities | 34 | % | 28 | % | ||||
| Wealth Management | 26 | % | 26 | % | ||||
| Investment Management | 18 | % | 13 | % | ||||
$ in millions, except per share data, worldwide employees and client assets | At March 31, 2024 | At December 31, 2023 | ||||||
Average liquidity resources for three months ended5 | $ | 318,664 | $ | 314,504 | ||||
Loans6 | $ | 227,145 | $ | 226,828 | ||||
| Total assets | $ | 1,228,503 | $ | 1,193,693 | ||||
| Deposits | $ | 352,494 | $ | 351,804 | ||||
| Borrowings | $ | 271,383 | $ | 263,732 | ||||
Common equity | $ | 90,448 | $ | 90,288 | ||||
Tangible common equity3 | $ | 66,813 | $ | 66,527 | ||||
| Common shares outstanding | 1,627 | 1,627 | ||||||
Book value per common share7 | $ | 55.60 | $ | 55.50 | ||||
Tangible book value per common share3, 7 | $ | 41.07 | $ | 40.89 | ||||
| Worldwide employees (in thousands) | 80 | 80 | ||||||
Client assets8 (in billions) | $ | 7,000 | $ | 6,588 | ||||
Capital Ratios9 | ||||||||
| Common Equity Tier 1 capital—Standardized | 15.0 | % | 15.2 | % | ||||
| Tier 1 capital—Standardized | 16.9 | % | 17.1 | % | ||||
| Common Equity Tier 1 capital—Advanced | 15.4 | % | 15.5 | % | ||||
| Tier 1 capital—Advanced | 17.3 | % | 17.4 | % | ||||
| Tier 1 leverage | 6.7 | % | 6.7 | % | ||||
| SLR | 5.4 | % | 5.5 | % | ||||
| March 2024 Form 10-Q | 7 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Net revenues | $ | 15,136 | $ | 14,517 | ||||
Adjustment for mark-to-market losses (gains) on DCP1 | (187) | (153) | ||||||
| Adjusted Net revenues—non-GAAP | $ | 14,949 | $ | 14,364 | ||||
| Compensation expense | $ | 6,696 | $ | 6,410 | ||||
Adjustment for mark-to-market gains (losses) on DCP1 | (249) | (193) | ||||||
| Adjusted Compensation expense—non-GAAP | $ | 6,447 | $ | 6,217 | ||||
| Wealth Management Net revenues | $ | 6,880 | $ | 6,559 | ||||
Adjustment for mark-to-market losses (gains) on DCP1 | (140) | (101) | ||||||
| Adjusted Wealth Management Net revenues—non-GAAP | $ | 6,740 | $ | 6,458 | ||||
| Wealth Management Compensation expense | $ | 3,788 | $ | 3,477 | ||||
Adjustment for mark-to-market gains (losses) on DCP1 | (156) | (119) | ||||||
| Adjusted Wealth Management Compensation expense—non-GAAP | $ | 3,632 | $ | 3,358 | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Tangible equity | ||||||||
Common equity | $ | 90,448 | $ | 90,288 | ||||
| Less: Goodwill and net intangible assets | (23,635) | (23,761) | ||||||
Tangible common equity—non-GAAP | $ | 66,813 | $ | 66,527 | ||||
| Average Monthly Balance | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Tangible equity | ||||||||
Common equity | $ | 89,913 | $ | 91,382 | ||||
| Less: Goodwill and net intangible assets | (23,705) | (24,198) | ||||||
Tangible common equity—non-GAAP | $ | 66,208 | $ | 67,184 | ||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2024 | 2023 | ||||||
Average common equity2 | ||||||||
| Institutional Securities | $ | 45.0 | $ | 45.6 | ||||
| Wealth Management | 29.1 | 28.8 | ||||||
| Investment Management | 10.8 | 10.4 | ||||||
ROE3 | ||||||||
| Institutional Securities | 15 | % | 12 | % | ||||
| Wealth Management | 19 | % | 19 | % | ||||
| Investment Management | 7 | % | 5 | % | ||||
Average tangible common equity2 | ||||||||
| Institutional Securities | $ | 44.6 | $ | 45.2 | ||||
| Wealth Management | 15.5 | 14.8 | ||||||
| Investment Management | 1.1 | 0.7 | ||||||
ROTCE3 | ||||||||
| Institutional Securities | 15 | % | 12 | % | ||||
| Wealth Management | 35 | % | 36 | % | ||||
| Investment Management | 68 | % | 73 | % | ||||
8 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| March 2024 Form 10-Q | 9 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2024 | 2023 | |||||||||
| Revenues | |||||||||||
| Advisory | $ | 461 | $ | 638 | (28) | % | |||||
| Equity | 430 | 202 | 113 | % | |||||||
| Fixed income | 556 | 407 | 37 | % | |||||||
| Total Underwriting | 986 | 609 | 62 | % | |||||||
| Total Investment banking | 1,447 | 1,247 | 16 | % | |||||||
| Equity | 2,842 | 2,729 | 4 | % | |||||||
| Fixed income | 2,485 | 2,576 | (4) | % | |||||||
| Other | 242 | 245 | (1) | % | |||||||
| Net revenues | $ | 7,016 | $ | 6,797 | 3 | % | |||||
| Provision for credit losses | 2 | 189 | (99) | % | |||||||
| Compensation and benefits | 2,343 | 2,365 | (1) | % | |||||||
| Non-compensation expenses | 2,320 | 2,351 | (1) | % | |||||||
| Total non-interest expenses | 4,663 | 4,716 | (1) | % | |||||||
| Income before provision for income taxes | 2,351 | 1,892 | 24 | % | |||||||
| Provision for income taxes | 482 | 363 | 33 | % | |||||||
| Net income | 1,869 | 1,529 | 22 | % | |||||||
| Net income applicable to noncontrolling interests | 50 | 51 | (2) | % | |||||||
| Net income applicable to Morgan Stanley | $ | 1,819 | $ | 1,478 | 23 | % | |||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2024 | 2023 | ||||||
Completed mergers and acquisitions1 | $ | 115 | $ | 128 | ||||
Equity and equity-related offerings2, 3 | 16 | 11 | ||||||
Fixed income offerings2, 4 | 95 | 63 | ||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
Net Interest2 | All Other3 | ||||||||||||||||
| $ in millions | Trading | Fees1 | Total | ||||||||||||||
| Financing | $ | 2,022 | $ | 136 | $ | (891) | $ | 1 | $ | 1,268 | |||||||
| Execution services | 972 | 609 | (41) | 34 | 1,574 | ||||||||||||
| Total Equity | $ | 2,994 | $ | 745 | $ | (932) | $ | 35 | $ | 2,842 | |||||||
| Total Fixed Income | $ | 2,594 | $ | 104 | $ | (292) | $ | 79 | $ | 2,485 | |||||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
Net Interest2 | All Other3 | ||||||||||||||||
| $ in millions | Trading | Fees1 | Total | ||||||||||||||
| Financing | $ | 1,696 | $ | 134 | $ | (541) | $ | 32 | $ | 1,321 | |||||||
| Execution services | 848 | 619 | (59) | — | 1,408 | ||||||||||||
| Total Equity | $ | 2,544 | $ | 753 | $ | (600) | $ | 32 | $ | 2,729 | |||||||
| Total Fixed Income | $ | 2,478 | $ | 109 | $ | (89) | $ | 78 | $ | 2,576 | |||||||
10 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| March 2024 Form 10-Q | 11 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2024 | 2023 | |||||||||
| Revenues | |||||||||||
| Asset management | $ | 3,829 | $ | 3,382 | 13 | % | |||||
Transactional1 | 1,033 | 921 | 12 | % | |||||||
| Net interest | 1,856 | 2,158 | (14) | % | |||||||
Other1 | 162 | 98 | 65 | % | |||||||
| Net revenues | 6,880 | 6,559 | 5 | % | |||||||
| Provision for credit losses | (8) | 45 | (118) | % | |||||||
| Compensation and benefits | 3,788 | 3,477 | 9 | % | |||||||
| Non-compensation expenses | 1,294 | 1,325 | (2) | % | |||||||
| Total non-interest expenses | 5,082 | 4,802 | 6 | % | |||||||
Income before provision for income taxes | $ | 1,806 | $ | 1,712 | 5 | % | |||||
| Provision for income taxes | 403 | 336 | 20 | % | |||||||
| Net income applicable to Morgan Stanley | $ | 1,403 | $ | 1,376 | 2 | % | |||||
| $ in billions | At March 31, 2024 | At December 31, 2023 | ||||||
Total client assets1 | $ | 5,495 | $ | 5,129 | ||||
| U.S. Bank Subsidiary loans | $ | 147 | $ | 147 | ||||
Margin and other lending2 | $ | 23 | $ | 21 | ||||
Deposits3 | $ | 347 | $ | 346 | ||||
Annualized weighted average cost of deposits4 | ||||||||
| Period end | 2.96% | 2.92% | ||||||
Period average for three months ended | 2.92% | 2.86% | ||||||
| Three Months Ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Net new assets | $ | 94.9 | $ | 109.6 | ||||
| $ in billions | At March 31, 2024 | At December 31, 2023 | ||||||
Advisor-led client assets1 | $ | 4,302 | $ | 3,979 | ||||
Fee-based client assets2 | $ | 2,124 | $ | 1,983 | ||||
| Fee-based client assets as a percentage of advisor-led client assets | 49% | 50% | ||||||
| Three Months Ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Fee-based asset flows3 | $ | 26.2 | $ | 22.4 | ||||
| At March 31, 2024 | At December 31, 2023 | |||||||
Self-directed client assets1 (in billions) | $ | 1,194 | $ | 1,150 | ||||
Self-directed households2 (in millions) | 8.1 | 8.1 | ||||||
| Three Months Ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Daily average revenue trades (“DARTs”)3 (in thousands) | 841 | 831 | ||||||
| At March 31, 2024 | At December 31, 2023 | |||||||
Stock plan unvested assets2 (in billions) | $ | 457 | $ | 416 | ||||
Stock plan participants3 (in millions) | 6.6 | 6.6 | ||||||
12 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At December 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | At March 31, 2024 | ||||||||||||
Separately managed4 | $ | 589 | $ | 16 | $ | (13) | $ | 39 | $ | 631 | |||||||
| Unified managed | 501 | 31 | (14) | 27 | 545 | ||||||||||||
| Advisor | 188 | 9 | (11) | 12 | 198 | ||||||||||||
| Portfolio manager | 645 | 32 | (24) | 35 | 688 | ||||||||||||
| Subtotal | $ | 1,923 | $ | 88 | $ | (62) | $ | 113 | $ | 2,062 | |||||||
| Cash management | 60 | 12 | (10) | — | 62 | ||||||||||||
Total fee-based client assets | $ | 1,983 | $ | 100 | $ | (72) | $ | 113 | $ | 2,124 | |||||||
| $ in billions | At December 31, 2022 | Inflows1 | Outflows2 | Market Impact3 | At March 31, 2023 | ||||||||||||
Separately managed4 | $ | 501 | $ | 16 | $ | (7) | $ | 18 | $ | 528 | |||||||
| Unified managed | 408 | 21 | (14) | 17 | 432 | ||||||||||||
| Advisor | 167 | 9 | (9) | 9 | 176 | ||||||||||||
| Portfolio manager | 552 | 26 | (20) | 20 | 578 | ||||||||||||
| Subtotal | $ | 1,628 | $ | 72 | $ | (50) | $ | 64 | $ | 1,714 | |||||||
| Cash management | 50 | 20 | (15) | — | 55 | ||||||||||||
Total fee-based client assets | $ | 1,678 | $ | 92 | $ | (65) | $ | 64 | $ | 1,769 | |||||||
| Three Months Ended March 31, | ||||||||
| Fee rate in bps | 2024 | 2023 | ||||||
| Separately managed | 12 | 13 | ||||||
| Unified managed | 91 | 93 | ||||||
| Advisor | 79 | 80 | ||||||
| Portfolio manager | 90 | 91 | ||||||
| Subtotal | 65 | 66 | ||||||
| Cash management | 6 | 6 | ||||||
| Total fee-based client assets | 63 | 65 | ||||||
| March 2024 Form 10-Q | 13 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | % Change | ||||||||||
| $ in millions | 2024 | 2023 | |||||||||
| Revenues | |||||||||||
| Asset management and related fees | $ | 1,346 | $ | 1,248 | 8 | % | |||||
Performance-based income and other1 | 31 | 41 | (24) | % | |||||||
| Net revenues | 1,377 | 1,289 | 7 | % | |||||||
| Compensation and benefits | 565 | 568 | (1) | % | |||||||
| Non-compensation expenses | 571 | 555 | 3 | % | |||||||
| Total non-interest expenses | 1,136 | 1,123 | 1 | % | |||||||
| Income before provision for income taxes | 241 | 166 | 45 | % | |||||||
| Provision for income taxes | 49 | 30 | 63 | % | |||||||
| Net income | 192 | 136 | 41 | % | |||||||
| Net income (loss) applicable to noncontrolling interests | — | 2 | (100) | % | |||||||
| Net income applicable to Morgan Stanley | $ | 192 | $ | 134 | 43 | % | |||||
| $ in billions | At Dec 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Mar 31, 2024 | ||||||||||||||
| Equity | $ | 295 | $ | 11 | $ | (16) | $ | 24 | $ | (4) | $ | 310 | ||||||||
Fixed Income | 171 | 17 | (13) | 1 | (2) | 174 | ||||||||||||||
| Alternatives and Solutions | 508 | 35 | (24) | 26 | (2) | 543 | ||||||||||||||
Long-Term AUM | $ | 974 | $ | 63 | $ | (53) | $ | 51 | $ | (8) | $ | 1,027 | ||||||||
| Liquidity and Overlay Services | 485 | 522 | (531) | 6 | (4) | 478 | ||||||||||||||
| Total | $ | 1,459 | $ | 585 | $ | (584) | $ | 57 | $ | (12) | $ | 1,505 | ||||||||
| $ in billions | At Dec 31, 2022 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Mar 31, 2023 | ||||||||||||||
| Equity | $ | 259 | $ | 10 | $ | (12) | $ | 21 | $ | (1) | $ | 277 | ||||||||
Fixed Income | 173 | 16 | (17) | 4 | (1) | 175 | ||||||||||||||
| Alternatives and Solutions | 431 | 18 | (16) | 15 | — | 448 | ||||||||||||||
Long-Term AUM | $ | 863 | $ | 44 | $ | (45) | $ | 40 | $ | (2) | $ | 900 | ||||||||
| Liquidity and Overlay Services | 442 | 585 | (568) | 6 | (3) | 462 | ||||||||||||||
| Total | $ | 1,305 | $ | 629 | $ | (613) | $ | 46 | $ | (5) | $ | 1,362 | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2024 | 2023 | ||||||
| Equity | $ | 302 | $ | 271 | ||||
| Fixed income | 172 | 175 | ||||||
| Alternatives and Solutions | 523 | 441 | ||||||
| Long-term AUM subtotal | 997 | 887 | ||||||
| Liquidity and Overlay Services | 482 | 442 | ||||||
| Total AUM | $ | 1,479 | $ | 1,329 | ||||
14 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| Fee rate in bps | 2024 | 2023 | ||||||
| Equity | 71 | 72 | ||||||
| Fixed income | 36 | 35 | ||||||
| Alternatives and Solutions | 29 | 33 | ||||||
| Long-term AUM | 43 | 45 | ||||||
| Liquidity and Overlay Services | 13 | 13 | ||||||
| Total AUM | 33 | 35 | ||||||
| March 2024 Form 10-Q | 15 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At March 31, 2024 | At December 31, 2023 | ||||||
| Investment securities: | ||||||||
| Available-for-sale at fair value | $ | 65.3 | $ | 66.6 | ||||
| Held-to-maturity | 50.7 | 51.4 | ||||||
| Total Investment securities | $ | 116.0 | $ | 118.0 | ||||
Wealth Management Loans2 | ||||||||
| Residential real estate | $ | 61.3 | $ | 60.3 | ||||
Securities-based lending and Other3 | 86.1 | 86.2 | ||||||
| Total, net of ACL | $ | 147.4 | $ | 146.5 | ||||
Institutional Securities Loans2 | ||||||||
| Corporate | $ | 7.9 | $ | 10.1 | ||||
| Secured lending facilities | 40.5 | 40.8 | ||||||
| Commercial and Residential real estate | 11.1 | 10.7 | ||||||
| Securities-based lending and Other | 4.4 | 4.1 | ||||||
| Total, net of ACL | $ | 63.9 | $ | 65.7 | ||||
| Total Assets | $ | 400.9 | $ | 396.1 | ||||
Deposits4 | $ | 346.6 | $ | 346.1 | ||||
16 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| At March 31, 2024 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 73,593 | $ | 28,550 | $ | 162 | $ | 102,305 | ||||||
| Trading assets at fair value | 353,117 | 9,177 | 5,339 | 367,633 | ||||||||||
| Investment securities | 38,562 | 114,171 | — | 152,733 | ||||||||||
| Securities purchased under agreements to resell | 102,295 | 20,438 | — | 122,733 | ||||||||||
| Securities borrowed | 131,780 | 1,072 | — | 132,852 | ||||||||||
| Customer and other receivables | 47,665 | 32,489 | 1,485 | 81,639 | ||||||||||
Loans1 | 69,811 | 147,405 | 4 | 217,220 | ||||||||||
Goodwill | 444 | 10,196 | 6,082 | 16,722 | ||||||||||
Intangible assets | 35 | 3,306 | 3,573 | 6,914 | ||||||||||
Other assets2 | 15,391 | 11,120 | 1,241 | 27,752 | ||||||||||
| Total assets | $ | 832,693 | $ | 377,924 | $ | 17,886 | $ | 1,228,503 | ||||||
| At December 31, 2023 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 72,928 | $ | 16,172 | $ | 132 | $ | 89,232 | ||||||
| Trading assets at fair value | 353,841 | 7,962 | 5,271 | 367,074 | ||||||||||
| Investment securities | 39,212 | 115,595 | — | 154,807 | ||||||||||
| Securities purchased under agreements to resell | 90,701 | 20,039 | — | 110,740 | ||||||||||
| Securities borrowed | 119,823 | 1,268 | — | 121,091 | ||||||||||
| Customer and other receivables | 47,333 | 31,237 | 1,535 | 80,105 | ||||||||||
Loans1 | 72,110 | 146,526 | 4 | 218,640 | ||||||||||
Goodwill | 424 | 10,199 | 6,084 | 16,707 | ||||||||||
Intangible assets | 26 | 3,427 | 3,602 | 7,055 | ||||||||||
Other assets2 | 14,108 | 12,743 | 1,391 | 28,242 | ||||||||||
| Total assets | $ | 810,506 | $ | 365,168 | $ | 18,019 | $ | 1,193,693 | ||||||
| March 2024 Form 10-Q | 17 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2024 | December 31, 2023 | ||||||
| Cash deposits with central banks | $ | 63,913 | $ | 64,205 | ||||
Unencumbered HQLA Securities1: | ||||||||
| U.S. government obligations | 140,628 | 137,635 | ||||||
| U.S. agency and agency mortgage-backed securities | 86,507 | 83,733 | ||||||
Non-U.S. sovereign obligations2 | 19,397 | 20,117 | ||||||
| Other investment grade securities | 969 | 678 | ||||||
Total HQLA1 | $ | 311,414 | $ | 306,368 | ||||
| Cash deposits with banks (non-HQLA) | 7,250 | 8,136 | ||||||
| Total Liquidity Resources | $ | 318,664 | $ | 314,504 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2024 | December 31, 2023 | ||||||
| Bank legal entities | ||||||||
| U.S. | $ | 139,457 | $ | 132,870 | ||||
| Non-U.S. | 5,661 | 5,359 | ||||||
| Total Bank legal entities | 145,118 | 138,229 | ||||||
| Non-Bank legal entities | ||||||||
| U.S.: | ||||||||
| Parent Company | 59,420 | 58,494 | ||||||
| Non-Parent Company | 56,059 | 56,459 | ||||||
| Total U.S. | 115,479 | 114,953 | ||||||
| Non-U.S. | 58,067 | 61,322 | ||||||
| Total Non-Bank legal entities | 173,546 | 176,275 | ||||||
| Total Liquidity Resources | $ | 318,664 | $ | 314,504 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2024 | December 31, 2023 | ||||||
Eligible HQLA | ||||||||
| Cash deposits with central banks | $ | 58,096 | $ | 58,047 | ||||
Securities1 | 192,944 | 194,970 | ||||||
Total Eligible HQLA | $ | 251,040 | $ | 253,017 | ||||
Net cash outflows | $ | 200,358 | $ | 196,488 | ||||
| LCR | 125 | % | 129 | % | ||||
18 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 255,585 | $ | 231,831 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 98,349 | $ | 77,708 | ||||
Securities received as collateral1 | $ | 3,357 | $ | 6,219 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | March 31, 2024 | December 31, 2023 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 228,978 | $ | 235,928 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 97,495 | $ | 87,285 | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Savings and demand deposits: | ||||||||
Brokerage sweep deposits1 | $ | 141,996 | $ | 148,274 | ||||
| Savings and other | 146,457 | 139,978 | ||||||
| Total Savings and demand deposits | 288,453 | 288,252 | ||||||
Time deposits2 | 64,041 | 63,552 | ||||||
Total3 | $ | 352,494 | $ | 351,804 | ||||
| $ in millions | Parent Company | Subsidiaries | Total | ||||||||
| Original maturities of one year or less | $ | — | $ | 5,233 | $ | 5,233 | |||||
| Original maturities greater than one year | |||||||||||
| 2024 | $ | 6,433 | $ | 6,755 | $ | 13,188 | |||||
| 2025 | 20,183 | 14,023 | 34,206 | ||||||||
| 2026 | 24,314 | 11,429 | 35,743 | ||||||||
| 2027 | 20,603 | 7,506 | 28,109 | ||||||||
| 2028 | 11,245 | 10,366 | 21,611 | ||||||||
| Thereafter | 98,284 | 35,009 | 133,293 | ||||||||
| Total greater than one year | $ | 181,062 | $ | 85,088 | $ | 266,150 | |||||
| Total | $ | 181,062 | $ | 90,321 | $ | 271,383 | |||||
Maturities over next 12 months2 | $ | 19,701 | |||||||||
| March 2024 Form 10-Q | 19 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Parent Company | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| DBRS, Inc. | R-1 (middle) | A (high) | Stable | ||||||||
| Fitch Ratings, Inc. | F1 | A+ | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | A1 | Stable | ||||||||
| Rating and Investment Information, Inc. | a-1 | A+ | Stable | ||||||||
| S&P Global Ratings | A-2 | A- | Stable | ||||||||
| MSBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| MSPBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| Three Months Ended March 31, | ||||||||
| in millions, except for per share data | 2024 | 2023 | ||||||
| Number of shares | 12 | 16 | ||||||
| Average price per share | $ | 86.79 | $ | 95.16 | ||||
| Total | $ | 1,000 | $ | 1,500 | ||||
| Announcement date | April 16, 2024 | ||||
| Amount per share | $0.85 | ||||
| Date to be paid | May 15, 2024 | ||||
| Shareholders of record as of | April 30, 2024 | ||||
20 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
At March 31, 2024 and December 31, 2023 | ||||||||
| Standardized | Advanced | |||||||
| Capital buffers | ||||||||
| Capital conservation buffer | — | 2.5% | ||||||
SCB1 | 5.4% | N/A | ||||||
G-SIB capital surcharge2 | 3.0% | 3.0% | ||||||
CCyB3 | 0% | 0% | ||||||
| Capital buffer requirement | 8.4% | 5.5% | ||||||
| Regulatory Minimum | At March 31, 2024 and December 31, 2023 | ||||||||||
| Standardized | Advanced | ||||||||||
Required ratios1 | |||||||||||
CET1 capital ratio | 4.5 | % | 12.9% | 10.0% | |||||||
| Tier 1 capital ratio | 6.0 | % | 14.4% | 11.5% | |||||||
| Total capital ratio | 8.0 | % | 16.4% | 13.5% | |||||||
| March 2024 Form 10-Q | 21 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Standardized | Advanced | ||||||||||||||||
| $ in millions | At March 31, 2024 | At Dec 31, 2023 | At March 31, 2024 | At Dec 31, 2023 | |||||||||||||
Risk-based capital | |||||||||||||||||
| CET1 capital | $ | 70,298 | $ | 69,448 | $ | 70,298 | $ | 69,448 | |||||||||
| Tier 1 capital | 79,046 | 78,183 | 79,046 | 78,183 | |||||||||||||
| Total capital | 91,007 | 88,874 | 90,239 | 88,190 | |||||||||||||
| Total RWA | 467,763 | 456,053 | 456,511 | 448,154 | |||||||||||||
Risk-based capital ratios | |||||||||||||||||
| CET1 capital | 15.0 | % | 15.2 | % | 15.4 | % | 15.5 | % | |||||||||
| Tier 1 capital | 16.9 | % | 17.1 | % | 17.3 | % | 17.4 | % | |||||||||
| Total capital | 19.5 | % | 19.5 | % | 19.8 | % | 19.7 | % | |||||||||
Required ratios1 | |||||||||||||||||
| CET1 capital | 12.9 | % | 12.9 | % | 10.0 | % | 10.0 | % | |||||||||
| Tier 1 capital | 14.4 | % | 14.4 | % | 11.5 | % | 11.5 | % | |||||||||
| Total capital | 16.4 | % | 16.4 | % | 13.5 | % | 13.5 | % | |||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Leveraged-based capital | ||||||||
Adjusted average assets1 | $ | 1,178,369 | $ | 1,159,626 | ||||
Supplementary leverage exposure2 | 1,464,030 | 1,429,552 | ||||||
Leveraged-based capital ratios | ||||||||
| Tier 1 leverage | 6.7 | % | 6.7 | % | ||||
| SLR | 5.4 | % | 5.5 | % | ||||
Required ratios3 | ||||||||
| Tier 1 leverage | 4.0 | % | 4.0 | % | ||||
| SLR | 5.0 | % | 5.0 | % | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | Change | ||||||||
CET1 capital | |||||||||||
Common shareholders' equity | $ | 90,448 | $ | 90,288 | $ | 160 | |||||
Regulatory adjustments and deductions | |||||||||||
| Net goodwill | (16,392) | (16,394) | 2 | ||||||||
| Net intangible assets | (5,394) | (5,509) | 115 | ||||||||
Impact of CECL transition | 62 | 124 | (62) | ||||||||
Other adjustments and deductions1 | 1,574 | 939 | 635 | ||||||||
Total CET1 capital | $ | 70,298 | $ | 69,448 | $ | 850 | |||||
| Additional Tier 1 capital | |||||||||||
| Preferred stock | $ | 8,750 | $ | 8,750 | $ | — | |||||
| Noncontrolling interests | 756 | 758 | (2) | ||||||||
| Additional Tier 1 capital | $ | 9,506 | $ | 9,508 | $ | (2) | |||||
| Deduction for investments in covered funds | (758) | (773) | 15 | ||||||||
| Total Tier 1 capital | $ | 79,046 | $ | 78,183 | $ | 863 | |||||
| Standardized Tier 2 capital | |||||||||||
| Subordinated debt | $ | 10,032 | $ | 8,760 | $ | 1,272 | |||||
| Eligible ACL | 2,090 | 2,051 | 39 | ||||||||
| Other adjustments and deductions | (161) | (120) | (41) | ||||||||
| Total Standardized Tier 2 capital | $ | 11,961 | $ | 10,691 | $ | 1,270 | |||||
| Total Standardized capital | $ | 91,007 | $ | 88,874 | $ | 2,133 | |||||
| Advanced Tier 2 capital | |||||||||||
| Subordinated debt | $ | 10,032 | $ | 8,760 | $ | 1,272 | |||||
| Eligible credit reserves | 1,322 | 1,367 | (45) | ||||||||
| Other adjustments and deductions | (161) | (120) | (41) | ||||||||
| Total Advanced Tier 2 capital | $ | 11,193 | $ | 10,007 | $ | 1,186 | |||||
| Total Advanced capital | $ | 90,239 | $ | 88,190 | $ | 2,049 | |||||
22 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, 2024 | ||||||||
| $ in millions | Standardized | Advanced | ||||||
| Credit risk RWA | ||||||||
| Balance at December 31, 2023 | $ | 407,731 | $ | 297,858 | ||||
| Change related to the following items: | ||||||||
| Derivatives | 1,072 | (4,757) | ||||||
| Securities financing transactions | 4,273 | 288 | ||||||
| Investment securities | (578) | (1,307) | ||||||
| Commitments, guarantees and loans | 373 | 7,051 | ||||||
| Equity investments | (22) | (241) | ||||||
| Other credit risk | 3,205 | 3,508 | ||||||
| Total change in credit risk RWA | $ | 8,323 | $ | 4,542 | ||||
| Balance at March 31, 2024 | $ | 416,054 | $ | 302,400 | ||||
| Market risk RWA | ||||||||
| Balance at December 31, 2023 | $ | 48,322 | $ | 48,201 | ||||
| Change related to the following items: | ||||||||
| Regulatory VaR | 1,336 | 1,336 | ||||||
| Regulatory stressed VaR | (738) | (738) | ||||||
| Incremental risk charge | 1,047 | 1,047 | ||||||
| Comprehensive risk measure | 81 | 202 | ||||||
| Specific risk | 1,661 | 1,661 | ||||||
| Total change in market risk RWA | $ | 3,387 | $ | 3,508 | ||||
| Balance at March 31, 2024 | $ | 51,709 | $ | 51,709 | ||||
| Operational risk RWA | ||||||||
| Balance at December 31, 2023 | N/A | $ | 102,095 | |||||
| Change in operational risk RWA | N/A | 307 | ||||||
| Balance at March 31, 2024 | N/A | $ | 102,402 | |||||
| Total RWA | $ | 467,763 | $ | 456,511 | ||||
| Actual Amount/Ratio | ||||||||||||||
| $ in millions | Regulatory Minimum | Required Ratio1 | At March 31, 2024 | At December 31, 2023 | ||||||||||
External TLAC2 | $ | 257,108 | $ | 250,914 | ||||||||||
| External TLAC as a % of RWA | 18.0 | % | 21.5 | % | 55.0 | % | 55.0 | % | ||||||
| External TLAC as a % of leverage exposure | 7.5 | % | 9.5 | % | 17.6 | % | 17.6 | % | ||||||
Eligible LTD3 | $ | 167,788 | $ | 162,547 | ||||||||||
| Eligible LTD as a % of RWA | 9.0 | % | 9.0 | % | 35.9 | % | 35.6 | % | ||||||
| Eligible LTD as a % of leverage exposure | 4.5 | % | 4.5 | % | 11.5 | % | 11.4 | % | ||||||
| March 2024 Form 10-Q | 23 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in billions | 2024 | 2023 | ||||||
| Institutional Securities | $ | 45.0 | $ | 45.6 | ||||
| Wealth Management | 29.1 | 28.8 | ||||||
| Investment Management | 10.8 | 10.4 | ||||||
Parent Company | 5.0 | 6.6 | ||||||
| Total | $ | 89.9 | $ | 91.4 | ||||
24 | March 2024 Form 10-Q | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| March 2024 Form 10-Q | 25 | |||||||
| Three Months Ended | ||||||||||||||
| March 31, 2024 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 40 | $ | 40 | $ | 52 | $ | 27 | ||||||
| Equity price | 23 | 21 | 24 | 17 | ||||||||||
| Foreign exchange rate | 8 | 9 | 15 | 6 | ||||||||||
| Commodity price | 18 | 13 | 18 | 10 | ||||||||||
Less: Diversification benefit2 | (36) | (35) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 53 | $ | 48 | $ | 58 | $ | 38 | ||||||
| Credit Portfolio | 25 | 24 | 25 | 22 | ||||||||||
Less: Diversification benefit2 | (18) | (18) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 60 | $ | 54 | $ | 62 | $ | 43 | ||||||
| Three Months Ended | ||||||||||||||
| December 31, 2023 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 29 | $ | 31 | $ | 39 | $ | 27 | ||||||
| Equity price | 19 | 22 | 38 | 15 | ||||||||||
| Foreign exchange rate | 6 | 7 | 14 | 5 | ||||||||||
| Commodity price | 11 | 13 | 20 | 10 | ||||||||||
Less: Diversification benefit2 | (27) | (35) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 38 | $ | 38 | $ | 45 | $ | 33 | ||||||
| Credit Portfolio | 25 | 22 | 25 | 19 | ||||||||||
Less: Diversification benefit2 | (22) | (14) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 41 | $ | 46 | $ | 54 | $ | 41 | ||||||
26 | March 2024 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||


| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Derivatives | $ | 5 | $ | 6 | ||||
| Borrowings carried at fair value | 49 | 48 | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Basis point change | ||||||||
| +100 | $ | 561 | $ | 585 | ||||
| -100 | (590) | (609) | ||||||
| March 2024 Form 10-Q | 27 | |||||||
| Risk Disclosures | ![]() | ||||
| Loss from 10% Decline | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Investments related to Investment Management activities | $ | 528 | $ | 481 | ||||
| Other investments: | ||||||||
| MUMSS | 129 | 134 | ||||||
| Other Firm investments | 408 | 399 | ||||||
| At March 31, 2024 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 7,171 | $ | 9,655 | $ | — | $ | 16,826 | ||||||
| Secured lending facilities | 38,692 | 3,564 | — | 42,256 | ||||||||||
| Commercial and Residential real estate | 8,689 | 205 | 4,479 | 13,373 | ||||||||||
| Securities-based lending and Other | 2,687 | — | 4,985 | 7,672 | ||||||||||
| Total Institutional Securities | 57,239 | 13,424 | 9,464 | 80,127 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 61,339 | 2 | — | 61,341 | ||||||||||
| Securities-based lending and Other | 86,353 | — | — | 86,353 | ||||||||||
| Total Wealth Management | 147,692 | 2 | — | 147,694 | ||||||||||
Total Investment Management2 | 4 | — | 461 | 465 | ||||||||||
| Total loans | 204,935 | 13,426 | 9,925 | 228,286 | ||||||||||
| ACL | (1,141) | (1,141) | ||||||||||||
| Total loans, net of ACL | $ | 203,794 | $ | 13,426 | $ | 9,925 | $ | 227,145 | ||||||
Lending commitments3 | $ | 134,938 | $ | 22,148 | $ | 600 | $ | 157,686 | ||||||
| Total exposure | $ | 338,732 | $ | 35,574 | $ | 10,525 | $ | 384,831 | ||||||
| At December 31, 2023 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 6,758 | $ | 11,862 | $ | — | $ | 18,620 | ||||||
| Secured lending facilities | 39,498 | 3,161 | — | 42,659 | ||||||||||
| Commercial and Residential real estate | 8,678 | 209 | 3,331 | 12,218 | ||||||||||
| Securities-based lending and Other | 2,818 | — | 4,402 | 7,220 | ||||||||||
| Total Institutional Securities | 57,752 | 15,232 | 7,733 | 80,717 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 60,375 | 22 | — | 60,397 | ||||||||||
| Securities-based lending and Other | 86,423 | 1 | — | 86,424 | ||||||||||
| Total Wealth Management | 146,798 | 23 | — | 146,821 | ||||||||||
Total Investment Management2 | 4 | — | 455 | 459 | ||||||||||
| Total loans | 204,554 | 15,255 | 8,188 | 227,997 | ||||||||||
| ACL | (1,169) | (1,169) | ||||||||||||
| Total loans, net of ACL | $ | 203,385 | $ | 15,255 | $ | 8,188 | $ | 226,828 | ||||||
Lending commitments3 | $ | 128,134 | $ | 21,329 | $ | 510 | $ | 149,973 | ||||||
| Total exposure | $ | 331,519 | $ | 36,584 | $ | 8,698 | $ | 376,801 | ||||||
28 | March 2024 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| $ in millions | Three Months Ended March 31, 2024 | ||||
| ACL—Loans | |||||
| Beginning balance | $ | 1,169 | |||
| Provision for credit losses | (22) | ||||
| Other | (6) | ||||
Ending balance | $ | 1,141 | |||
ACL—Lending commitments | |||||
| Beginning balance | $ | 551 | |||
| Provision for credit losses | 16 | ||||
| Other | (2) | ||||
Ending balance | $ | 565 | |||
Total ending balance | $ | 1,706 | |||
| Three Months Ended March 31, 2024 | |||||||||||
| $ in millions | IS | WM | Total | ||||||||
| Loans | $ | (16) | $ | (6) | $ | (22) | |||||
| Lending commitments | 18 | (2) | 16 | ||||||||
| Total | $ | 2 | $ | (8) | $ | (6) | |||||
4Q 2024 | 4Q 2025 | |||||||
| Year-over-year growth rate | 1.0 | % | 2.0 | % | ||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| IS | WM | IS | WM | |||||||||||
| Accrual | 99.0 | % | 99.7 | % | 98.9 | % | 99.8 | % | ||||||
Nonaccrual1 | 1.0 | % | 0.3 | % | 1.1 | % | 0.2 | % | ||||||
| At March 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 1 | $ | 11 | $ | 68 | $ | — | $ | 80 | |||||||
| A | 1,316 | 1,068 | 176 | — | 2,560 | ||||||||||||
| BBB | 5,455 | 9,821 | 389 | — | 15,665 | ||||||||||||
| BB | 10,925 | 18,090 | 2,525 | 315 | 31,855 | ||||||||||||
| Other NIG | 9,356 | 11,661 | 2,851 | 171 | 24,039 | ||||||||||||
Unrated2 | 271 | 1,509 | 94 | 3,202 | 5,076 | ||||||||||||
| Total loans, net of ACL | 27,324 | 42,160 | 6,103 | 3,688 | 79,275 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 50 | — | — | 50 | ||||||||||||
| AA | 2,531 | 3,164 | 586 | — | 6,281 | ||||||||||||
| A | 6,627 | 21,372 | 970 | — | 28,969 | ||||||||||||
| BBB | 9,623 | 47,594 | 890 | — | 58,107 | ||||||||||||
| BB | 3,238 | 18,980 | 3,809 | 465 | 26,492 | ||||||||||||
| Other NIG | 1,497 | 14,817 | 2,296 | 3 | 18,613 | ||||||||||||
Unrated2 | 4 | 24 | 222 | — | 250 | ||||||||||||
| Total lending commitments | 23,520 | 106,001 | 8,773 | 468 | 138,762 | ||||||||||||
| Total exposure | $ | 50,844 | $ | 148,161 | $ | 14,876 | $ | 4,156 | $ | 218,037 | |||||||
| March 2024 Form 10-Q | 29 | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2023 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 3 | $ | 11 | $ | 216 | $ | — | $ | 230 | |||||||
| A | 1,054 | 950 | 182 | — | 2,186 | ||||||||||||
| BBB | 7,117 | 10,076 | 346 | — | 17,539 | ||||||||||||
| BB | 11,723 | 16,367 | 1,775 | 277 | 30,142 | ||||||||||||
| Other NIG | 9,586 | 12,961 | 2,924 | 156 | 25,627 | ||||||||||||
Unrated2 | 111 | 1,036 | 62 | 2,910 | 4,119 | ||||||||||||
| Total loans, net of ACL | 29,594 | 41,401 | 5,505 | 3,343 | 79,843 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 50 | — | — | 50 | ||||||||||||
| AA | 2,610 | 3,064 | 154 | — | 5,828 | ||||||||||||
| A | 7,704 | 21,256 | 593 | — | 29,553 | ||||||||||||
| BBB | 9,161 | 46,304 | 106 | — | 55,571 | ||||||||||||
| BB | 4,069 | 16,431 | 1,594 | 414 | 22,508 | ||||||||||||
| Other NIG | 1,916 | 13,842 | 1,077 | 3 | 16,838 | ||||||||||||
Unrated2 | 6 | 7 | — | — | 13 | ||||||||||||
| Total lending commitments | 25,466 | 100,954 | 3,524 | 417 | 130,361 | ||||||||||||
| Total exposure | $ | 55,060 | $ | 142,355 | $ | 9,029 | $ | 3,760 | $ | 210,204 | |||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Industry | ||||||||
| Financials | $ | 61,171 | $ | 57,804 | ||||
| Real estate | 35,543 | 35,342 | ||||||
| Industrials | 17,780 | 18,056 | ||||||
| Communications services | 15,348 | 15,301 | ||||||
| Consumer discretionary | 14,653 | 12,190 | ||||||
| Information technology | 14,501 | 12,430 | ||||||
| Healthcare | 13,251 | 14,274 | ||||||
| Utilities | 11,102 | 11,522 | ||||||
| Consumer staples | 9,588 | 9,305 | ||||||
| Energy | 9,468 | 9,156 | ||||||
| Materials | 6,671 | 6,503 | ||||||
| Insurance | 6,329 | 6,486 | ||||||
| Other | 2,632 | 1,835 | ||||||
| Total exposure | $ | 218,037 | $ | 210,204 | ||||
| At March 31, 2024 | ||||||||||||||
| Contractual Years to Maturity | ||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | Total | ||||||||||
| Loans, net of ACL | $ | 2,096 | $ | 693 | $ | 2,562 | $ | 5,351 | ||||||
| Lending commitments | 1,537 | 1,069 | 1,552 | 4,158 | ||||||||||
| Total exposure | $ | 3,633 | $ | 1,762 | $ | 4,114 | $ | 9,509 | ||||||
| At December 31, 2023 | ||||||||||||||
| Contractual Years to Maturity | ||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | Total | ||||||||||
| Loans, net of ACL | $ | 1,974 | $ | 2,564 | $ | 2,580 | $ | 7,118 | ||||||
| Lending commitments | 3,564 | 685 | 549 | 4,798 | ||||||||||
| Total exposure | $ | 5,538 | $ | 3,249 | $ | 3,129 | $ | 11,916 | ||||||
| At March 31, 2024 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 7,171 | $ | 96,771 | $ | 103,942 | |||||
| Secured lending facilities | 38,692 | 18,045 | 56,737 | ||||||||
| Commercial real estate | 8,689 | 351 | 9,040 | ||||||||
| Securities-based lending and Other | 2,687 | 847 | 3,534 | ||||||||
| Total, before ACL | $ | 57,239 | $ | 116,014 | $ | 173,253 | |||||
| ACL | $ | (852) | $ | (548) | $ | (1,400) | |||||
| At December 31, 2023 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 6,758 | $ | 91,752 | $ | 98,510 | |||||
| Secured lending facilities | 39,498 | 15,589 | 55,087 | ||||||||
| Commercial real estate | 8,678 | 266 | 8,944 | ||||||||
| Securities-based lending and Other | 2,818 | 915 | 3,733 | ||||||||
| Total, before ACL | $ | 57,752 | $ | 108,522 | $ | 166,274 | |||||
| ACL | $ | (874) | $ | (533) | $ | (1,407) | |||||
30 | March 2024 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
| At March 31, 2024 | At December 31, 2023 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total | Loans1 | LC1 | Total | |||||||||||||||||
| Americas | $ | 6,066 | $ | 286 | $ | 6,352 | $ | 5,410 | $ | 289 | $ | 5,699 | |||||||||||
| EMEA | 3,223 | 158 | 3,381 | 3,127 | 56 | 3,183 | |||||||||||||||||
| Asia | 545 | 2 | 547 | 485 | — | 485 | |||||||||||||||||
Total | $ | 9,834 | $ | 446 | $ | 10,280 | $ | 9,022 | $ | 345 | $ | 9,367 | |||||||||||
| At March 31, 2024 | At December 31, 2023 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total | Loans1 | LC1 | Total | |||||||||||||||||
| Office | $ | 3,143 | $ | 167 | $ | 3,310 | $ | 3,310 | $ | 186 | $ | 3,496 | |||||||||||
| Industrial | 2,898 | 111 | 3,009 | 2,435 | 5 | 2,440 | |||||||||||||||||
| Multifamily | 1,802 | 93 | 1,895 | 1,715 | 74 | 1,789 | |||||||||||||||||
| Hotel | 1,013 | 69 | 1,082 | 718 | 73 | 791 | |||||||||||||||||
| Retail | 978 | 6 | 984 | 842 | 7 | 849 | |||||||||||||||||
| Other | — | — | — | 2 | — | 2 | |||||||||||||||||
Total | $ | 9,834 | $ | 446 | $ | 10,280 | $ | 9,022 | $ | 345 | $ | 9,367 | |||||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Other | Total | ||||||||||||
| ACL—Loans | |||||||||||||||||
Beginning balance | $ | 241 | $ | 153 | $ | 463 | $ | 17 | $ | 874 | |||||||
Provision (release) | 1 | (17) | 1 | (1) | (16) | ||||||||||||
| Other | (1) | (1) | (3) | (1) | (6) | ||||||||||||
Ending balance | $ | 241 | $ | 135 | $ | 461 | $ | 15 | $ | 852 | |||||||
ACL—Lending commitments | |||||||||||||||||
Beginning balance | $ | 431 | $ | 70 | $ | 26 | $ | 6 | $ | 533 | |||||||
Provision (release) | (2) | 25 | (3) | (2) | 18 | ||||||||||||
| Other | (3) | (1) | — | 1 | (3) | ||||||||||||
Ending balance | $ | 426 | $ | 94 | $ | 23 | $ | 5 | $ | 548 | |||||||
Total ending balance | $ | 667 | $ | 229 | $ | 484 | $ | 20 | $ | 1,400 | |||||||
| At March 31, 2024 | At December 31, 2023 | |||||||
| Corporate | 3.4 | % | 3.6 | % | ||||
| Secured lending facilities | 0.3 | % | 0.4 | % | ||||
| Commercial real estate | 5.3 | % | 5.3 | % | ||||
| Securities-based lending and Other | 0.6 | % | 0.6 | % | ||||
| Total Institutional Securities loans | 1.5 | % | 1.5 | % | ||||
| At March 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 76,968 | $ | 7,751 | $ | 1,302 | $ | 132 | $ | 86,153 | |||||||
Residential real estate | 1 | 101 | 1,214 | 59,936 | 61,252 | ||||||||||||
| Total loans, net of ACL | $ | 76,969 | $ | 7,852 | $ | 2,516 | $ | 60,068 | $ | 147,405 | |||||||
| Lending commitments | 15,966 | 2,582 | 16 | 360 | 18,924 | ||||||||||||
| Total exposure | $ | 92,935 | $ | 10,434 | $ | 2,532 | $ | 60,428 | $ | 166,329 | |||||||
| At December 31, 2023 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 76,923 | $ | 7,679 | $ | 1,494 | $ | 133 | $ | 86,229 | |||||||
Residential real estate | 1 | 91 | 1,255 | 58,950 | 60,297 | ||||||||||||
| Total loans, net of ACL | $ | 76,924 | $ | 7,770 | $ | 2,749 | $ | 59,083 | $ | 146,526 | |||||||
| Lending commitments | 16,312 | 2,937 | 19 | 344 | 19,612 | ||||||||||||
| Total exposure | $ | 93,236 | $ | 10,707 | $ | 2,768 | $ | 59,427 | $ | 166,138 | |||||||
| March 2024 Form 10-Q | 31 | |||||||
| Risk Disclosures | ![]() | ||||
| At March 31, 2024 | At December 31, 2023 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total | Loans1 | LC1 | Total | |||||||||||||||||
| Retail | $ | 2,297 | $ | — | $ | 2,297 | $ | 2,180 | $ | 3 | $ | 2,183 | |||||||||||
| Multifamily | 1,965 | 187 | 2,152 | 1,891 | 159 | 2,050 | |||||||||||||||||
| Office | 1,734 | 16 | 1,750 | 1,736 | 16 | 1,752 | |||||||||||||||||
| Industrial | 452 | — | 452 | 454 | — | 454 | |||||||||||||||||
| Hotel | 387 | — | 387 | 400 | — | 400 | |||||||||||||||||
| Other | 249 | — | 249 | 253 | — | 253 | |||||||||||||||||
Total | $ | 7,084 | $ | 203 | $ | 7,287 | $ | 6,914 | $ | 178 | $ | 7,092 | |||||||||||
| Three Months Ended March 31, 2024 | |||||||||||
| $ in millions | Residential Real Estate | SBL and Other | Total | ||||||||
| ACL—Loans | |||||||||||
| Beginning balance | $ | 100 | $ | 195 | $ | 295 | |||||
| Provision (release) | (11) | 5 | (6) | ||||||||
Ending balance | $ | 89 | $ | 200 | $ | 289 | |||||
| ACL—Lending commitments | |||||||||||
| Beginning balance | $ | 4 | $ | 14 | $ | 18 | |||||
| Provision (release) | — | (2) | (2) | ||||||||
| Other | — | 1 | 1 | ||||||||
Ending balance | $ | 4 | $ | 13 | $ | 17 | |||||
Total ending balance | $ | 93 | $ | 213 | $ | 306 | |||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Institutional Securities | $ | 24,071 | $ | 24,208 | ||||
| Wealth Management | 23,393 | 21,436 | ||||||
| Total | $ | 47,464 | $ | 45,644 | ||||
32 | March 2024 Form 10-Q | |||||||
| Risk Disclosures | ![]() | ||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| At March 31, 2024 | ||||||||||||||||||||
| Less than 1 year | $ | 1,161 | $ | 10,878 | $ | 33,637 | $ | 19,901 | $ | 8,625 | $ | 74,202 | ||||||||
| 1-3 years | 1,124 | 6,575 | 17,723 | 10,978 | 6,582 | 42,982 | ||||||||||||||
| 3-5 years | 1,107 | 7,777 | 8,493 | 5,249 | 3,914 | 26,540 | ||||||||||||||
| Over 5 years | 3,119 | 28,963 | 48,383 | 27,306 | 7,059 | 114,830 | ||||||||||||||
| Total, gross | $ | 6,511 | $ | 54,193 | $ | 108,236 | $ | 63,434 | $ | 26,180 | $ | 258,554 | ||||||||
| Counterparty netting | (3,099) | (41,773) | (80,599) | (44,702) | (14,299) | (184,472) | ||||||||||||||
| Cash and securities collateral | (2,475) | (10,237) | (24,557) | (13,362) | (6,101) | (56,732) | ||||||||||||||
| Total, net | $ | 937 | $ | 2,183 | $ | 3,080 | $ | 5,370 | $ | 5,780 | $ | 17,350 | ||||||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| At December 31, 2023 | ||||||||||||||||||||
| Less than 1 year | $ | 2,013 | $ | 16,885 | $ | 37,517 | $ | 25,529 | $ | 10,084 | $ | 92,028 | ||||||||
| 1-3 years | 1,013 | 7,274 | 18,451 | 12,757 | 7,360 | 46,855 | ||||||||||||||
| 3-5 years | 504 | 8,897 | 8,814 | 5,989 | 3,825 | 28,029 | ||||||||||||||
| Over 5 years | 3,955 | 29,511 | 50,512 | 28,003 | 6,597 | 118,578 | ||||||||||||||
| Total, gross | $ | 7,485 | $ | 62,567 | $ | 115,294 | $ | 72,278 | $ | 27,866 | $ | 285,490 | ||||||||
| Counterparty netting | (3,691) | (48,821) | (86,826) | (53,178) | (15,888) | (208,404) | ||||||||||||||
| Cash and securities collateral | (2,709) | (10,704) | (25,921) | (13,025) | (5,554) | (57,913) | ||||||||||||||
| Total, net | $ | 1,085 | $ | 3,042 | $ | 2,547 | $ | 6,075 | $ | 6,424 | $ | 19,173 | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Industry | ||||||||
| Financials | $ | 5,511 | $ | 7,215 | ||||
| Utilities | 4,606 | 4,267 | ||||||
| Regional governments | 1,181 | 1,319 | ||||||
| Industrials | 940 | 937 | ||||||
| Communications services | 802 | 841 | ||||||
| Energy | 643 | 533 | ||||||
| Consumer discretionary | 590 | 684 | ||||||
| Information technology | 521 | 677 | ||||||
| Healthcare | 481 | 468 | ||||||
| Consumer staples | 477 | 515 | ||||||
| Materials | 358 | 383 | ||||||
| Sovereign governments | 247 | 262 | ||||||
| Insurance | 160 | 156 | ||||||
| Real estate | 136 | 167 | ||||||
| Not-for-profit organizations | 135 | 166 | ||||||
| Other | 562 | 583 | ||||||
| Total | $ | 17,350 | $ | 19,173 | ||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | United Kingdom | France | Germany | Brazil | China | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | 122 | $ | 2,407 | $ | (713) | $ | 5,064 | $ | 2,161 | |||||||
Net counterparty exposure2 | 14 | — | 120 | 3 | 334 | ||||||||||||
| Exposure before hedges | 136 | 2,407 | (593) | 5,067 | 2,495 | ||||||||||||
Hedges3 | (55) | (6) | (253) | (154) | — | ||||||||||||
| Net exposure | $ | 81 | $ | 2,401 | $ | (846) | $ | 4,913 | $ | 2,495 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 1,476 | $ | 1,113 | $ | 852 | $ | 129 | $ | 2,293 | |||||||
Net counterparty exposure2 | 6,737 | 2,977 | 2,920 | 329 | 171 | ||||||||||||
| Loans | 7,192 | 721 | 1,404 | 381 | 344 | ||||||||||||
| Lending commitments | 9,736 | 3,091 | 5,500 | 456 | 666 | ||||||||||||
| Exposure before hedges | 25,141 | 7,902 | 10,676 | 1,295 | 3,474 | ||||||||||||
Hedges3 | (1,963) | (2,112) | (2,031) | (14) | (1) | ||||||||||||
| Net exposure | $ | 23,178 | $ | 5,790 | $ | 8,645 | $ | 1,281 | $ | 3,473 | |||||||
| Total net exposure | $ | 23,259 | $ | 8,191 | $ | 7,799 | $ | 6,194 | $ | 5,968 | |||||||
| $ in millions | Japan | India | Korea | Canada | Australia | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | (42) | $ | 2,450 | $ | 3,054 | $ | 838 | $ | 117 | |||||||
Net counterparty exposure2 | 17 | — | 387 | 15 | 91 | ||||||||||||
| Exposure before hedges | (25) | 2,450 | 3,441 | 853 | 208 | ||||||||||||
Hedges3 | — | — | — | — | — | ||||||||||||
| Net exposure | $ | (25) | $ | 2,450 | $ | 3,441 | $ | 853 | $ | 208 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 1,426 | $ | 979 | $ | 37 | $ | 259 | $ | 208 | |||||||
Net counterparty exposure2 | 4,766 | 1,317 | 822 | 1,002 | 722 | ||||||||||||
| Loans | 23 | 116 | — | 316 | 1,719 | ||||||||||||
| Lending commitments | — | — | — | 1,703 | 936 | ||||||||||||
| Exposure before hedges | 6,215 | 2,412 | 859 | 3,280 | 3,585 | ||||||||||||
Hedges3 | (234) | — | — | (106) | (14) | ||||||||||||
| Net exposure | $ | 5,981 | $ | 2,412 | $ | 859 | $ | 3,174 | $ | 3,571 | |||||||
| Total net exposure | $ | 5,956 | $ | 4,862 | $ | 4,300 | $ | 4,027 | $ | 3,779 | |||||||
| March 2024 Form 10-Q | 33 | |||||||
| Risk Disclosures | ![]() | ||||
| $ in millions | At March 31, 2024 | |||||||
| Country of Risk | Collateral2 | |||||||
| United Kingdom | U.K., U.S., and France | $ | 8,039 | |||||
| Japan | Japan and U.S. | 5,831 | ||||||
| Other | U.S., Italy and France | 15,119 | ||||||
34 | March 2024 Form 10-Q | |||||||
/s/ Deloitte & Touche LLP | ||
| New York, New York | ||
| May 3, 2024 | ||
| March 2024 Form 10-Q | 35 | |||||||
| Consolidated Income Statement (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| in millions, except per share data | 2024 | 2023 | ||||||
| Revenues | ||||||||
| Investment banking | $ | $ | ||||||
| Trading | ||||||||
| Investments | ||||||||
| Commissions and fees | ||||||||
| Asset management | ||||||||
| Other | ||||||||
| Total non-interest revenues | ||||||||
Interest income1 | ||||||||
Interest expense1 | ||||||||
| Net interest | ||||||||
| Net revenues | ||||||||
| Provision for credit losses | ( | |||||||
| Non-interest expenses | ||||||||
| Compensation and benefits | ||||||||
| Brokerage, clearing and exchange fees | ||||||||
| Information processing and communications | ||||||||
| Professional services | ||||||||
| Occupancy and equipment | ||||||||
| Marketing and business development | ||||||||
| Other | ||||||||
| Total non-interest expenses | ||||||||
| Income before provision for income taxes | ||||||||
| Provision for income taxes | ||||||||
| Net income | $ | $ | ||||||
| Net income applicable to noncontrolling interests | ||||||||
| Net income applicable to Morgan Stanley | $ | $ | ||||||
| Preferred stock dividends | ||||||||
| Earnings applicable to Morgan Stanley common shareholders | $ | $ | ||||||
| Earnings per common share | ||||||||
| Basic | $ | $ | ||||||
| Diluted | $ | $ | ||||||
| Average common shares outstanding | ||||||||
| Basic | ||||||||
| Diluted | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Net income | $ | $ | ||||||
| Other comprehensive income (loss), net of tax: | ||||||||
| Foreign currency translation adjustments | ( | |||||||
| Change in net unrealized gains (losses) on available-for-sale securities | ||||||||
| Pension and other | ( | |||||||
| Change in net debt valuation adjustment | ( | ( | ||||||
| Net change in cash flow hedges | ( | |||||||
| Total other comprehensive income (loss) | $ | ( | $ | |||||
| Comprehensive income | $ | $ | ||||||
| Net income applicable to noncontrolling interests | ||||||||
| Other comprehensive income (loss) applicable to noncontrolling interests | ( | ( | ||||||
| Comprehensive income applicable to Morgan Stanley | $ | $ | ||||||
| March 2024 Form 10-Q | 36 | See Notes to Consolidated Financial Statements | ||||||
| Consolidated Balance Sheet | ![]() | ||||
| $ in millions, except share data | (Unaudited) At March 31, 2024 | At December 31, 2023 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
Trading assets at fair value ($ | ||||||||
| Investment securities: | ||||||||
Available-for-sale at fair value (amortized cost of $ | ||||||||
Held-to-maturity (fair value of $ | ||||||||
Securities purchased under agreements to resell (includes $ | ||||||||
| Securities borrowed | ||||||||
| Customer and other receivables | ||||||||
| Loans: | ||||||||
Held for investment (net of allowance for credit losses of $ | ||||||||
| Held for sale | ||||||||
| Goodwill | ||||||||
Intangible assets (net of accumulated amortization of $ | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities | ||||||||
Deposits (includes $ | $ | $ | ||||||
| Trading liabilities at fair value | ||||||||
Securities sold under agreements to repurchase (includes $ | ||||||||
| Securities loaned | ||||||||
Other secured financings (includes $ | ||||||||
| Customer and other payables | ||||||||
| Other liabilities and accrued expenses | ||||||||
Borrowings (includes $ | ||||||||
| Total liabilities | ||||||||
| Commitments and contingent liabilities (see Note 13) | ||||||||
| Morgan Stanley shareholders’ equity: | ||||||||
| Preferred stock | ||||||||
Common stock, $ | ||||||||
Shares authorized: | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Employee stock trusts | ||||||||
| Accumulated other comprehensive income (loss) | ( | ( | ||||||
Common stock held in treasury at cost, $ | ( | ( | ||||||
| Common stock issued to employee stock trusts | ( | ( | ||||||
| Total Morgan Stanley shareholders’ equity | ||||||||
| Noncontrolling interests | ||||||||
| Total equity | ||||||||
| Total liabilities and equity | $ | $ | ||||||
| See Notes to Consolidated Financial Statements | 37 | March 2024 Form 10-Q | ||||||
Consolidated Statement of Changes in Total Equity (Unaudited) | ![]() | |||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Preferred Stock | ||||||||
| Beginning and ending balance | ||||||||
| Common Stock | ||||||||
| Beginning and ending balance | ||||||||
| Additional Paid-in Capital | ||||||||
| Beginning balance | ||||||||
| Share-based award activity | ( | ( | ||||||
| Ending balance | ||||||||
| Retained Earnings | ||||||||
| Beginning balance | ||||||||
Cumulative adjustment related to the adoption of an accounting standard update1 | ( | |||||||
| Net income applicable to Morgan Stanley | ||||||||
Preferred stock dividends2 | ( | ( | ||||||
Common stock dividends2 | ( | ( | ||||||
| Other net increases (decreases) | ( | ( | ||||||
| Ending balance | ||||||||
| Employee Stock Trusts | ||||||||
| Beginning balance | ||||||||
| Share-based award activity | ( | |||||||
| Ending balance | ||||||||
| Accumulated Other Comprehensive Income (Loss) | ||||||||
| Beginning balance | ( | ( | ||||||
| Net change in Accumulated other comprehensive income (loss) | ( | |||||||
| Ending balance | ( | ( | ||||||
| Common Stock Held in Treasury at Cost | ||||||||
| Beginning balance | ( | ( | ||||||
| Share-based award activity | ||||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ||||||
| Ending balance | ( | ( | ||||||
| Common Stock Issued to Employee Stock Trusts | ||||||||
| Beginning balance | ( | ( | ||||||
| Share-based award activity | ( | |||||||
| Ending balance | ( | ( | ||||||
| Noncontrolling Interests | ||||||||
| Beginning balance | ||||||||
| Net income applicable to noncontrolling interests | ||||||||
| Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests | ( | ( | ||||||
| Other net increases (decreases) | ||||||||
| Ending balance | ||||||||
| Total Equity | $ | $ | ||||||
| March 2024 Form 10-Q | 38 | See Notes to Consolidated Financial Statements | ||||||
| Consolidated Cash Flow Statement (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Cash flows from operating activities | ||||||||
| Net income | $ | $ | ||||||
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | ||||||||
| Stock-based compensation expense | ||||||||
| Depreciation and amortization | ||||||||
| Provision for credit losses | ( | |||||||
| Other operating adjustments | ( | |||||||
| Changes in assets and liabilities: | ||||||||
| Trading assets, net of Trading liabilities | ( | |||||||
| Securities borrowed | ( | ( | ||||||
| Securities loaned | ( | |||||||
| Customer and other receivables and other assets | ||||||||
| Customer and other payables and other liabilities | ||||||||
| Securities purchased under agreements to resell | ( | ( | ||||||
| Securities sold under agreements to repurchase | ( | |||||||
| Net cash provided by (used for) operating activities | ( | |||||||
| Cash flows from investing activities | ||||||||
| Proceeds from (payments for): | ||||||||
| Other assets—Premises, equipment and software | ( | ( | ||||||
| Changes in loans, net | ( | ( | ||||||
| AFS securities: | ||||||||
| Purchases | ( | ( | ||||||
| Proceeds from sales | ||||||||
| Proceeds from paydowns and maturities | ||||||||
| HTM securities: | ||||||||
| Purchases | ( | |||||||
| Proceeds from paydowns and maturities | ||||||||
| Other investing activities | ( | ( | ||||||
| Net cash provided by (used for) investing activities | ( | |||||||
| Cash flows from financing activities | ||||||||
| Net proceeds from (payments for): | ||||||||
| Other secured financings | ||||||||
| Deposits | ( | |||||||
| Proceeds from issuance of Borrowings | ||||||||
| Payments for: | ||||||||
| Borrowings | ( | ( | ||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ||||||
| Cash dividends | ( | ( | ||||||
| Other financing activities | ( | |||||||
| Net cash provided by (used for) financing activities | ( | |||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | |||||||
| Net increase (decrease) in cash and cash equivalents | ( | |||||||
| Cash and cash equivalents, at beginning of period | ||||||||
| Cash and cash equivalents, at end of period | $ | $ | ||||||
| Supplemental Disclosure of Cash Flow Information | ||||||||
| Cash payments for: | ||||||||
| Interest | $ | $ | ||||||
| Income taxes, net of refunds | ||||||||
| See Notes to Consolidated Financial Statements | 39 | March 2024 Form 10-Q | ||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| March 2024 Form 10-Q | 40 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Cash and due from banks | $ | $ | ||||||
| Interest bearing deposits with banks | ||||||||
| Total Cash and cash equivalents | $ | $ | ||||||
| Restricted cash | $ | $ | ||||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3,5 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4,5 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities—AFS | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
41 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At December 31, 2023 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities—AFS | — | ||||||||||||||||
| Securities purchased under agreements to resell | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At December 31, 2023 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Commercial Real Estate | $ | $ | ||||||
| Residential Real Estate | ||||||||
| Securities-based lending and Other loans | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Customer and other receivables (payables), net | $ | $ | ||||||
| March 2024 Form 10-Q | 42 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| U.S. Treasury and agency securities | ||||||||
| Beginning balance | $ | $ | ||||||
| Purchases | ( | |||||||
| Sales | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| Other sovereign government obligations | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| State and municipal securities | ||||||||
| Beginning balance | $ | $ | ||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| MABS | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Loans and lending commitments | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Purchases and originations | ||||||||
| Sales | ( | ( | ||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | ( | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Corporate and other debt | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases and originations | ||||||||
| Sales | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| Corporate equities | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | ( | ||||
| Investments | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Sales | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Investment securities—AFS | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ||||||
| Net derivatives: Interest rate | ||||||||
| Beginning balance | $ | ( | $ | ( | ||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ( | |||||
| Unrealized gains (losses) | $ | $ | ||||||
43 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Net derivatives: Credit | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | ( | ||||
| Net derivatives: Foreign exchange | ||||||||
| Beginning balance | $ | ( | $ | |||||
| Realized and unrealized gains (losses) | ( | |||||||
| Purchases | ||||||||
| Issuances | ( | |||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | $ | ( | |||||
| Net derivatives: Equity | ||||||||
| Beginning balance | $ | ( | $ | ( | ||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | |||||||
| Net transfers | ( | |||||||
| Ending balance | $ | ( | $ | ( | ||||
| Unrealized gains (losses) | $ | $ | ( | |||||
| Net derivatives: Commodity and other | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized gains (losses) | ||||||||
| Purchases | ||||||||
| Issuances | ( | ( | ||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized gains (losses) | $ | ( | $ | |||||
| Deposits | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Issuances | ||||||||
| Settlements | ( | |||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Nonderivative trading liabilities | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ( | |||||||
| Purchases | ( | ( | ||||||
| Sales | ||||||||
| Net transfers | ||||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ( | |||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Securities sold under agreements to repurchase | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Settlements | ( | |||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Other secured financings | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ( | |||||||
| Issuances | ||||||||
| Settlements | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | ( | $ | |||||
| Borrowings | ||||||||
| Beginning balance | $ | $ | ||||||
| Realized and unrealized losses (gains) | ||||||||
| Issuances | ||||||||
| Settlements | ( | ( | ||||||
| Net transfers | ( | ( | ||||||
| Ending balance | $ | $ | ||||||
| Unrealized losses (gains) | $ | $ | ||||||
| Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA | ||||||||
| March 2024 Form 10-Q | 44 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
Balance / Range (Average1) | ||||||||
| $ in millions, except inputs | At March 31, 2024 | At December 31, 2023 | ||||||
| Assets at Fair Value on a Recurring Basis | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| State and municipal securities | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | N/M | |||||||
| MABS | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| Loans and lending commitments | $ | $ | ||||||
| Margin loan model: | ||||||||
| Margin loan rate | ||||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Corporate and other debt | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| Corporate equities | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Investments | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| WACC | ||||||||
| Exit multiple | ||||||||
| Market approach: | ||||||||
| EBITDA multiple | ||||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Net derivative and other contracts: | ||||||||
| Interest rate | $ | $ | ( | |||||
| Option model: | ||||||||
| IR volatility skew | ||||||||
| IR curve correlation | ||||||||
| Bond volatility | ||||||||
| Inflation volatility | ||||||||
| Credit | $ | $ | ||||||
| Credit default swap model: | ||||||||
| Cash-synthetic basis | ||||||||
| Bond price | ||||||||
| Credit spread | ||||||||
| Funding spread | ||||||||
Balance / Range (Average1) | ||||||||
| $ in millions, except inputs | At March 31, 2024 | At December 31, 2023 | ||||||
Foreign exchange2 | $ | $ | ( | |||||
| Option model: | ||||||||
| IR curve | - | - | ||||||
| Foreign exchange volatility skew | N/M | - | ||||||
| Contingency probability | ||||||||
Equity2 | $ | ( | $ | ( | ||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| FX correlation | - | - | ||||||
| IR correlation | ||||||||
| Commodity and other | $ | $ | ||||||
| Option model: | ||||||||
| Forward power price | $ | $ | ||||||
| Commodity volatility | ||||||||
| Cross-commodity correlation | ||||||||
| Liabilities Measured at Fair Value on a Recurring Basis | ||||||||
| Deposits | $ | N/M | ||||||
| Option model: | ||||||||
| Equity volatility | N/M | |||||||
| Securities sold under agreements to repurchase | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| Funding spread | ||||||||
| Other secured financings | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Borrowings | $ | $ | ||||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| Equity - FX correlation | - | - | ||||||
| IR curve correlation | ||||||||
Credit default swap model: | ||||||||
| Credit spread | N/M | |||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| Nonrecurring Fair Value Measurement | ||||||||
| Loans | $ | $ | ||||||
| Corporate loan model: | ||||||||
| Credit spread | ||||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Warehouse model: | ||||||||
| Credit spread | ||||||||
45 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| $ in millions | Carrying Value | Commitment | Carrying Value | Commitment | ||||||||||
| Private equity | $ | $ | $ | $ | ||||||||||
| Real estate | ||||||||||||||
Hedge | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Carrying Value at March 31, 2024 | ||||||||
| $ in millions | Private Equity | Real Estate | ||||||
| Less than 5 years | $ | $ | ||||||
| 5-10 years | ||||||||
| Over 10 years | ||||||||
| Total | $ | $ | ||||||
| At March 31, 2024 | |||||||||||
| Fair Value | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| At December 31, 2023 | |||||||||||
| Fair Value | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | $ | $ | $ | ||||||||
| Other assets—Other investments | |||||||||||
| Other assets—ROU assets | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Assets | ||||||||
Loans2 | $ | ( | $ | |||||
Other assets—Premises, equipment and software3 | ( | |||||||
| Total | $ | ( | $ | |||||
| Liabilities | ||||||||
Other liabilities and accrued expenses—Lending commitments2 | $ | $ | ||||||
| Total | $ | $ | ||||||
| March 2024 Form 10-Q | 46 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
| Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1,2 | |||||||||||||||||
| Held for investment | |||||||||||||||||
| Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments3 | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2023 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
| Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1,2 | |||||||||||||||||
Held for investment | |||||||||||||||||
Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments3 | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Business Unit Responsible for Risk Management | ||||||||
| Equity | $ | $ | ||||||
| Interest rates | ||||||||
| Commodities | ||||||||
| Credit | ||||||||
| Foreign exchange | ||||||||
| Total | $ | $ | ||||||
47 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Trading revenues | $ | ( | $ | ( | ||||
| Interest expense | ||||||||
Net revenues1 | $ | ( | $ | ( | ||||
| Three Months Ended March 31, | ||||||||||||||
| 2024 | 2023 | |||||||||||||
| $ in millions | Trading Revenues | OCI | Trading Revenues | OCI | ||||||||||
Loans and other receivables1 | $ | $ | $ | ( | $ | |||||||||
| Lending commitments | ( | |||||||||||||
| Deposits | ( | |||||||||||||
| Borrowings | ( | ( | ( | ( | ||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Cumulative pre-tax DVA gain (loss) recognized in AOCI | $ | ( | $ | ( | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
Loans and other receivables2 | $ | $ | ||||||
Nonaccrual loans2 | ||||||||
Borrowings3 | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Nonaccrual loans | $ | $ | ||||||
| Nonaccrual loans 90 or more days past due | ||||||||
| Assets at March 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Liabilities at March 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading liabilities | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | |||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | ||||||||||||||
48 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Assets at December 31, 2023 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Liabilities at December 31, 2023 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading liabilities | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | ( | ||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
| Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable | $ | |||||||||||||
| Assets at March 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Liabilities at March 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Assets at December 31, 2023 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
49 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Liabilities at December 31, 2023 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange-Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Fair value hedges—Recognized in Interest income | ||||||||
| Interest rate contracts | $ | $ | ( | |||||
| Investment Securities—AFS | ( | |||||||
| Fair value hedges—Recognized in Interest expense | ||||||||
| Interest rate contracts | $ | ( | $ | |||||
| Deposits | ( | |||||||
| Borrowings | ( | |||||||
| Net investment hedges—Foreign exchange contracts | ||||||||
| Recognized in OCI | $ | $ | ( | |||||
| Forward points excluded from hedge effectiveness testing—Recognized in Interest income | ||||||||
Cash flow hedges—Interest rate contracts1 | ||||||||
| Recognized in OCI | $ | ( | $ | |||||
| Less: Realized gains (losses) (pre-tax) reclassified from AOCI to interest income | ( | ( | ||||||
| Net change in cash flow hedges included within AOCI | ( | |||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Investment Securities—AFS | ||||||||
| Amortized cost basis currently or previously hedged | $ | $ | ||||||
Basis adjustments included in amortized cost1 | $ | ( | $ | ( | ||||
| Deposits | ||||||||
Carrying amount currently or previously hedged | $ | $ | ||||||
Basis adjustments included in carrying amount1 | $ | ( | $ | ( | ||||
| Borrowings | ||||||||
Carrying amount currently or previously hedged | $ | $ | ||||||
Basis adjustments included in carrying amount—Outstanding hedges | $ | ( | $ | ( | ||||
Basis adjustments included in carrying amount—Terminated hedges | $ | ( | $ | ( | ||||
| Three Months Ended | ||||||||
| March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Recognized in Other revenues | ||||||||
Credit contracts1 | $ | ( | $ | ( | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Net derivative liabilities with credit risk-related contingent features | $ | $ | ||||||
| Collateral posted | ||||||||
| $ in millions | At March 31, 2024 | ||||
| One-notch downgrade | $ | ||||
| Two-notch downgrade | |||||
Bilateral downgrade agreements included in the amounts above1 | $ | ||||
| March 2024 Form 10-Q | 50 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Years to Maturity at March 31, 2024 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| Years to Maturity at December 31, 2023 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Single-name CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Index and basket CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Total CDS sold | $ | $ | ||||||
| Other credit contracts | ||||||||
| Total credit protection sold | $ | $ | ||||||
| Notional | ||||||||
| $ in billions | At March 31, 2024 | At December 31, 2023 | ||||||
| Single name | $ | $ | ||||||
| Index and basket | ||||||||
| Tranched index and basket | ||||||||
| Total | $ | $ | ||||||
| Fair Value Asset (Liability) | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Single name | $ | ( | $ | ( | ||||
| Index and basket | ( | ( | ||||||
| Tranched index and basket | ( | ( | ||||||
| Total | $ | ( | $ | ( | ||||
| At March 31, 2024 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | ||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
51 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At December 31, 2023 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | ||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| $ in millions | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||
| U.S. Treasury securities | ||||||||||||||
| Less than 12 months | $ | $ | $ | $ | ||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| U.S. agency securities | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| State and municipal securities | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| FFELP student loan ABS | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Total AFS securities in an unrealized loss position | ||||||||||||||
| Less than 12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| At March 31, 2024 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2,3 | ||||||||
| AFS securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | $ | $ | % | ||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| Due within 1 year | ( | % | |||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | ( | % | |||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| State and municipal securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 Years | % | ||||||||||
| Total | |||||||||||
| FFELP student loan ABS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Total AFS securities | % | ||||||||||
| March 2024 Form 10-Q | 52 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2 | ||||||||
| HTM securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Non-agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Total HTM securities | % | ||||||||||
| Total investment securities | % | ||||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Gross realized gains | $ | $ | ||||||
| Gross realized (losses) | ( | |||||||
Total1 | $ | $ | ||||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
| Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| At December 31, 2023 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
| Net amounts for which master netting agreements are not in place or may not be legally enforceable | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities— Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
53 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At December 31, 2023 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities— Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Securities sold under agreements to repurchase | ||||||||
| U.S. Treasury and agency securities | $ | $ | ||||||
| Other sovereign government obligations | ||||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Securities loaned | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total included in the offsetting disclosure | $ | $ | ||||||
| Trading liabilities—Obligation to return securities received as collateral | ||||||||
| Corporate equities | $ | $ | ||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Trading assets | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Collateral received with right to sell or repledge | $ | $ | ||||||
Collateral that was sold or repledged1 | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
Segregated securities1 | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Margin and other lending | $ | $ | ||||||
| March 2024 Form 10-Q | 54 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At December 31, 2023 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| $ in millions | Fixed Rate | Floating or Adjustable Rate | Fixed Rate | Floating or Adjustable Rate | ||||||||||
| Corporate | $ | $ | $ | $ | ||||||||||
| Secured lending facilities | ||||||||||||||
| Commercial real estate | ||||||||||||||
| Residential real estate | ||||||||||||||
Securities-based lending and Other | ||||||||||||||
| Total loans, before ACL | $ | $ | $ | $ | ||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||||||||
| Corporate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| 2020 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||||||||
| Secured Lending Facilities | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| 2020 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||||||||
| Commercial Real Estate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
| 2020 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2024 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
| 2020 | ||||||||||||||||||||||||||
| Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| At December 31, 2023 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
| 2020 | ||||||||||||||||||||||||||
Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
55 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | ||||||||||||||
Securities-based Lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
| Revolving | $ | $ | $ | $ | ||||||||||
| 2024 | ||||||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| 2020 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| December 31, 2023 | ||||||||||||||
Securities-based Lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
| Revolving | $ | $ | $ | $ | ||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| 2020 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Corporate | $ | $ | ||||||
| Commercial real estate | ||||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Corporate | $ | $ | ||||||
| Secured lending facilities | ||||||||
| Commercial real estate | ||||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
Total | $ | $ | ||||||
| Nonaccrual loans without an ACL | $ | $ | ||||||
| Three Months Ended March 31, | |||||||||||||||||
| 2024 | 2023 | ||||||||||||||||
| $ in millions | Amortized Cost | % of Total Loans2 | Amortized Cost | % of Total Loans2 | |||||||||||||
Term Extension | |||||||||||||||||
| Corporate | $ | % | $ | % | |||||||||||||
| Commercial real estate | % | % | |||||||||||||||
| Residential real estate | % | % | |||||||||||||||
| Securities-based lending and Other | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Other-than-insignificant Payment Delay | |||||||||||||||||
| Commercial real estate | $ | % | $ | % | |||||||||||||
| Total | $ | % | $ | % | |||||||||||||
Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay | |||||||||||||||||
| Commercial real estate | $ | % | $ | % | |||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Total Modifications | $ | % | $ | % | |||||||||||||
| March 2024 Form 10-Q | 56 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
Three Months Ended March 31, 20241 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Commercial real estate | % | |||||||||||||
| Securities-based lending and Other | % | |||||||||||||
| Multiple Modifications - Term Extension and Other-than-insignificant Payment Delay | ||||||||||||||
| Commercial real estate | $ | % | ||||||||||||
Three Months Ended March 31, 20231 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Commercial real estate | % | |||||||||||||
| Residential real estate | % | |||||||||||||
| At March 31, 2024 | |||||||||||
| $ in millions | 30-89 Days Past Due | 90+ Days Past Due | Total | ||||||||
| Commercial real estate | $ | $ | |||||||||
| Total | $ | $ | $ | ||||||||
| Three Months Ended March 31, 2024 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | ( | ( | |||||||||||||||||
| Other | ( | ( | ( | ( | ( | |||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
| ACL—Lending commitments | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | ( | ( | |||||||||||||||||
| Other | ( | ( | ( | |||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Three Months Ended March 31, 2023 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Gross charge-offs | ( | ( | ( | ( | ||||||||||||||||
| Provision (release) | ||||||||||||||||||||
| Other | ( | |||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
| ACL—Lending commitments | ||||||||||||||||||||
| Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||
| ACL for loans to total HFI loans | % | % | ||||||
Nonaccrual HFI loans to total HFI loans | % | % | ||||||
ACL for loans to nonaccrual HFI loans | % | % | ||||||
57 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
Currently employed by the Firm1 | $ | $ | ||||||
No longer employed by the Firm2 | ||||||||
| Employee loans | $ | $ | ||||||
| ACL | ( | ( | ||||||
| Employee loans, net of ACL | $ | $ | ||||||
| Remaining repayment term, weighted average in years | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Investments | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Income (loss) | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Income (loss) from investment in MUMSS | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Low-income housing | $ | $ | ||||||
Renewable energy and other1 | ||||||||
Total2 | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Income tax credits and other income tax benefits | $ | $ | ||||||
| Proportional amortization | ( | ( | ||||||
| Net benefits | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Savings and demand deposits | $ | $ | ||||||
| Time deposits | ||||||||
| Total | $ | $ | ||||||
| Deposits subject to FDIC insurance | $ | $ | ||||||
| Deposits not subject to FDIC insurance | $ | $ | ||||||
| $ in millions | At March 31, 2024 | ||||
| 2024 | $ | ||||
| 2025 | |||||
| 2026 | |||||
| 2027 | |||||
| 2028 | |||||
| Thereafter | |||||
| Total | $ | ||||
| March 2024 Form 10-Q | 58 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Original maturities of one year or less | $ | $ | ||||||
| Original maturities greater than one year | ||||||||
| Senior | $ | $ | ||||||
| Subordinated | ||||||||
| Total greater than one year | $ | $ | ||||||
| Total | $ | $ | ||||||
Weighted average stated maturity, in years1 | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Original maturities: | ||||||||
| One year or less | $ | $ | ||||||
| Greater than one year | ||||||||
| Total | $ | $ | ||||||
| Transfers of assets accounted for as secured financings | $ | $ | ||||||
| Years to Maturity at March 31, 2024 | |||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Lending: | |||||||||||||||||
| Corporate | $ | $ | $ | $ | $ | ||||||||||||
| Secured lending facilities | |||||||||||||||||
| Commercial and Residential real estate | |||||||||||||||||
| Securities-based lending and Other | |||||||||||||||||
Forward-starting secured financing receivables1 | |||||||||||||||||
| Central counterparty | |||||||||||||||||
| Investment activities | |||||||||||||||||
| Letters of credit and other financial guarantees | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Lending commitments participated to third parties | $ | ||||||||||||||||
| At March 31, 2024 | ||||||||||||||||||||
Maximum Potential Payout/Notional of Obligations by Years to Maturity | Carrying Amount Asset (Liability) | |||||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | ||||||||||||||||
Non-credit derivatives1 | $ | $ | $ | $ | $ | ( | ||||||||||||||
Standby letters of credit and other financial guarantees issued2,3 | ||||||||||||||||||||
| Liquidity facilities | ( | |||||||||||||||||||
| Whole loan sales guarantees | ||||||||||||||||||||
Securitization representations and warranties4 | ( | |||||||||||||||||||
| General partner guarantees | ( | |||||||||||||||||||
| Client clearing guarantees | ||||||||||||||||||||
59 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Legal expenses | $ | ( | $ | |||||
| March 2024 Form 10-Q | 60 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
61 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| March 2024 Form 10-Q | 62 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| $ in millions | VIE Assets | VIE Liabilities | VIE Assets | VIE Liabilities | ||||||||||
MABS1 | $ | $ | $ | $ | ||||||||||
Investment vehicles2 | ||||||||||||||
| MTOB | ||||||||||||||
| Other | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Trading assets at fair value | ||||||||
| Investment securities | ||||||||
| Securities purchased under agreements to resell | ||||||||
| Customer and other receivables | ||||||||
| Other assets | ||||||||
| Total | $ | $ | ||||||
| Liabilities | ||||||||
| Other secured financings | $ | $ | ||||||
| Other liabilities and accrued expenses | ||||||||
| Borrowings | ||||||||
| Total | $ | $ | ||||||
| Noncontrolling interests | $ | $ | ||||||
63 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| At March 31, 2024 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Carrying value of variable interests—Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2023 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Carrying value of variable interests–Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
| At March 31, 2024 | At December 31, 2023 | |||||||||||||
| $ in millions | UPB | Debt and Equity Interests | UPB | Debt and Equity Interests | ||||||||||
| Residential mortgages | $ | $ | $ | $ | ||||||||||
| Commercial mortgages | ||||||||||||||
| U.S. agency collateralized mortgage obligations | ||||||||||||||
| Other consumer or commercial loans | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| At March 31, 2024 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2,3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| At December 31, 2023 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2,3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| March 2024 Form 10-Q | 64 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Fair Value At March 31, 2024 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
Fair Value at December 31, 2023 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
New transactions1 | $ | $ | ||||||
| Retained interests | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
Gross cash proceeds from sale of assets1 | $ | $ | ||||||
| Fair value | ||||||||
| Assets sold | $ | $ | ||||||
| Derivative assets recognized in the balance sheet | ||||||||
| Derivative liabilities recognized in the balance sheet | ||||||||
65 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
At March 31, 2024 and December 31, 2023 | ||||||||
| Standardized | Advanced | |||||||
| Capital buffers | ||||||||
| Capital conservation buffer | — | |||||||
| SCB | N/A | |||||||
| G-SIB capital surcharge | ||||||||
CCyB1 | ||||||||
| Capital buffer requirement | ||||||||
| Regulatory Minimum | At March 31, 2024 and December 31, 2023 | ||||||||||
| Standardized | Advanced | ||||||||||
Required ratios1 | |||||||||||
CET1 capital ratio | % | ||||||||||
| Tier 1 capital ratio | % | ||||||||||
| Total capital ratio | % | ||||||||||
| Standardized | ||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
Risk-based capital | ||||||||
| CET1 capital | $ | $ | ||||||
| Tier 1 capital | ||||||||
| Total capital | ||||||||
| Total RWA | ||||||||
| Risk-based capital ratio | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
Required ratio1 | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Leveraged-based capital | ||||||||
Adjusted average assets1 | $ | $ | ||||||
Supplementary leverage exposure2 | ||||||||
| Leveraged-based capital ratio | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
Required ratio3 | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
| March 2024 Form 10-Q | 66 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Well-Capitalized Requirement | Required Ratio1 | At March 31, 2024 | At December 31, 2023 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
| CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| Well-Capitalized Requirement | Required Ratio1 | At March 31, 2024 | At December 31, 2023 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
| CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Net capital | $ | $ | ||||||
| Excess net capital | ||||||||
| Shares Outstanding | Carrying Value | |||||||||||||
| $ in millions, except per share data | At March 31, 2024 | Liquidation Preference per Share | At March 31, 2024 | At December 31, 2023 | ||||||||||
| Series | ||||||||||||||
| A | $ | $ | $ | |||||||||||
C1 | ||||||||||||||
| E | ||||||||||||||
| F | ||||||||||||||
| I | ||||||||||||||
| K | ||||||||||||||
| L | ||||||||||||||
| M | ||||||||||||||
| N | ||||||||||||||
| O | ||||||||||||||
| P | ||||||||||||||
| Total | $ | $ | ||||||||||||
| Shares authorized | ||||||||||||||
67 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Repurchases of common stock under the Firm’s Share Repurchase Authorization | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| in millions | 2024 | 2023 | ||||||
| Weighted average common shares outstanding, basic | ||||||||
| Effect of dilutive RSUs and PSUs | ||||||||
| Weighted average common shares outstanding and common stock equivalents, diluted | ||||||||
| Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS) | ||||||||
| $ in millions, except per share data | Three Months Ended March 31, 2024 | Three Months Ended March 31, 2023 | ||||||||||||
Per Share1 | Total | Per Share1 | Total | |||||||||||
| Preferred stock series | ||||||||||||||
| A | $ | $ | $ | $ | ||||||||||
| C | ||||||||||||||
| E | ||||||||||||||
| F | ||||||||||||||
| I | ||||||||||||||
| K | ||||||||||||||
| L | ||||||||||||||
M2 | ||||||||||||||
N | ||||||||||||||
| O | ||||||||||||||
| P | ||||||||||||||
| Total Preferred stock | $ | $ | ||||||||||||
| Common stock | $ | $ | $ | $ | ||||||||||
| $ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
| December 31, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| OCI during the period | ( | ( | ( | ( | ||||||||||||||||
| March 31, 2024 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| December 31, 2022 | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| OCI during the period | ( | ( | ||||||||||||||||||
| March 31, 2023 | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| $ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
| CTA | |||||||||||||||||
| OCI activity | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||
| Reclassified to earnings | |||||||||||||||||
| Net OCI | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | |||||||
| Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ( | ( | ||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Pension and other | |||||||||||||||||
| OCI activity | $ | $ | $ | $ | $ | ||||||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Change in net DVA | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Change in fair value of cash flow hedge derivatives | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
| $ in millions | Pre-tax Gain (Loss) | Income Tax Benefit (Provision) | After-tax Gain (Loss) | Non-controlling Interests | Net | ||||||||||||
| CTA | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | $ | ( | $ | ||||||||||
| Reclassified to earnings | |||||||||||||||||
| Net OCI | $ | ( | $ | $ | $ | ( | $ | ||||||||||
| Change in net unrealized gains (losses) on AFS securities | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | ( | ( | ( | ||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| Pension and other | |||||||||||||||||
| OCI activity | $ | $ | $ | $ | $ | ||||||||||||
| Reclassified to earnings | ( | ( | ( | ||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | $ | ( | |||||||||
| Change in net DVA | |||||||||||||||||
| OCI activity | $ | ( | $ | $ | ( | $ | ( | $ | ( | ||||||||
| Reclassified to earnings | ( | ||||||||||||||||
| Net OCI | $ | ( | $ | $ | ( | $ | ( | $ | ( | ||||||||
| Change in fair value of cash flow hedge derivatives | |||||||||||||||||
| OCI activity | $ | $ | ( | $ | $ | $ | |||||||||||
| Reclassified to earnings | |||||||||||||||||
| Net OCI | $ | $ | ( | $ | $ | $ | |||||||||||
| March 2024 Form 10-Q | 68 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Interest income | ||||||||
Cash and cash equivalents1 | $ | |||||||
| Investment securities | ||||||||
| Loans | ||||||||
Securities purchased under agreements to resell2 | ||||||||
Securities borrowed3 | ||||||||
| Trading assets, net of Trading liabilities | ||||||||
Customer receivables and Other1, 4 | ||||||||
| Total interest income | $ | $ | ||||||
| Interest expense | ||||||||
| Deposits | $ | $ | ||||||
| Borrowings | ||||||||
Securities sold under agreements to repurchase5 | ||||||||
Securities loaned6 | ||||||||
Customer payables and Other4, 7 | ||||||||
| Total interest expense | $ | $ | ||||||
| Net interest | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Customer and other receivables | $ | $ | ||||||
| Customer and other payables | ||||||||
| Three Months Ended March 31, 2024 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1,2 | ( | ||||||||||||||||
| Other | ( | ||||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
| Interest income | ( | ||||||||||||||||
| Interest expense | ( | ||||||||||||||||
| Net interest | ( | ( | |||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | $ | $ | ( | $ | $ | $ | ( | ||||||||||
| Compensation and benefits | |||||||||||||||||
| Non-compensation expenses | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
69 | March 2024 Form 10-Q | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, 2023 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1,2 | ( | ||||||||||||||||
| Other | ( | ( | |||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
Interest income3 | ( | ||||||||||||||||
Interest expense3 | ( | ||||||||||||||||
| Net interest | ( | ||||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | $ | $ | $ | $ | $ | ||||||||||||
| Compensation and benefits | |||||||||||||||||
| Non-compensation expenses | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Institutional Securities Advisory | $ | $ | ||||||
| Institutional Securities Underwriting | ||||||||
| Firm Investment banking revenues from contracts with customers | % | % | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Interest rate | $ | $ | ||||||
| Foreign exchange | ||||||||
Equity1 | ||||||||
| Commodity and other | ||||||||
| Credit | ( | |||||||
| Total | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Net cumulative unrealized performance-based fees at risk of reversing | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Fee waivers | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Transaction taxes | $ | $ | ||||||
| March 2024 Form 10-Q | 70 | |||||||
| Notes to Consolidated Financial Statements (Unaudited) | ![]() | ||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Americas | $ | $ | ||||||
| EMEA | ||||||||
| Asia | ||||||||
| Total | $ | $ | ||||||
| Three Months Ended March 31, | ||||||||
| $ in millions | 2024 | 2023 | ||||||
| Non-interest revenues | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Customer and other receivables | $ | $ | ||||||
| $ in millions | At March 31, 2024 | At December 31, 2023 | ||||||
| Institutional Securities | $ | $ | ||||||
| Wealth Management | ||||||||
| Investment Management | ||||||||
Total1 | $ | $ | ||||||
71 | March 2024 Form 10-Q | |||||||
| Three Months Ended March 31, | ||||||||||||||||||||
| 2024 | 2023 | |||||||||||||||||||
| $ in millions | Average Daily Balance | Interest | Annualized Average Rate | Average Daily Balance | Interest | Annualized Average Rate | ||||||||||||||
| Interest earning assets | ||||||||||||||||||||
Cash and Cash Equivalents1: | ||||||||||||||||||||
U.S. | $ | 52,696 | $ | 633 | 4.8 | % | $ | 61,795 | $ | 531 | 3.5 | % | ||||||||
Non-U.S. | 43,661 | 270 | 2.5 | % | 53,663 | 212 | 1.6 | % | ||||||||||||
Investment securities2 | 153,866 | 1,197 | 3.1 | % | 159,061 | 1,018 | 2.6 | % | ||||||||||||
Loans2 | 217,921 | 3,305 | 6.1 | % | 214,185 | 2,815 | 5.3 | % | ||||||||||||
Securities purchased under agreements to resell3: | ||||||||||||||||||||
| U.S. | 52,260 | 1,496 | 11.5 | % | 46,847 | 932 | 8.1 | % | ||||||||||||
| Non-U.S. | 49,595 | 1,034 | 8.4 | % | 65,713 | 545 | 3.4 | % | ||||||||||||
Securities borrowed4: | ||||||||||||||||||||
| U.S. | 108,288 | 1,257 | 4.7 | % | 123,206 | 1,095 | 3.6 | % | ||||||||||||
| Non-U.S. | 18,835 | 119 | 2.5 | % | 18,683 | 77 | 1.7 | % | ||||||||||||
Trading assets, net of Trading liabilities: | ||||||||||||||||||||
| U.S. | 107,970 | 1,175 | 4.4 | % | 87,631 | 786 | 3.6 | % | ||||||||||||
| Non-U.S. | 18,329 | 207 | 4.5 | % | 7,264 | 127 | 7.1 | % | ||||||||||||
Customer receivables and Other1,10: | ||||||||||||||||||||
| U.S. | 47,180 | 1,700 | 14.5 | % | 45,260 | 1,252 | 11.2 | % | ||||||||||||
| Non-U.S. | 17,502 | 537 | 12.3 | % | 15,625 | 590 | 15.3 | % | ||||||||||||
| Total | $ | 888,103 | $ | 12,930 | 5.9 | % | $ | 898,933 | $ | 9,980 | 4.5 | % | ||||||||
| Interest bearing liabilities | ||||||||||||||||||||
Deposits2 | $ | 346,946 | $ | 2,476 | 2.9 | % | $ | 346,973 | $ | 1,575 | 1.8 | % | ||||||||
Borrowings2,5 | 251,956 | 3,223 | 5.1 | % | 245,600 | 2,506 | 4.1 | % | ||||||||||||
Securities sold under agreements to repurchase6,8: | ||||||||||||||||||||
| U.S. | 24,410 | 1,221 | 20.1 | % | 21,075 | 670 | 12.9 | % | ||||||||||||
| Non-U.S. | 58,316 | 1,181 | 8.1 | % | 41,071 | 548 | 5.4 | % | ||||||||||||
Securities loaned7,8: | ||||||||||||||||||||
| U.S. | 5,790 | 17 | 1.2 | % | 4,992 | 13 | 1.1 | % | ||||||||||||
| Non-U.S. | 8,979 | 207 | 9.3 | % | 10,016 | 151 | 6.1 | % | ||||||||||||
Customer payables and Other9,10: | ||||||||||||||||||||
| U.S. | 124,018 | 1,891 | 6.1 | % | 137,766 | 1,402 | 4.1 | % | ||||||||||||
| Non-U.S. | 64,756 | 918 | 5.7 | % | 65,818 | 769 | 4.7 | % | ||||||||||||
| Total | $ | 885,171 | $ | 11,134 | 5.1 | % | $ | 873,311 | $ | 7,634 | 3.5 | % | ||||||||
| Net interest income and net interest rate spread | $ | 1,796 | 0.8 | % | $ | 2,346 | 1.0 | % | ||||||||||||
| March 2024 Form 10-Q | 72 | |||||||
| Glossary of Common Terms and Acronyms | ![]() | ||||
2023 Form 10-K | Annual report on Form 10-K for year ended December 31, 2023 filed with the SEC | ||||
| ABS | Asset-backed securities | ||||
| ACL | Allowance for credit losses | ||||
| AFS | Available-for-sale | ||||
| AML | Anti-money laundering | ||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| AUM | Assets under management or supervision | ||||
| Balance sheet | Consolidated balance sheet | ||||
| BHC | Bank holding company | ||||
| bps | Basis points; one basis point equals 1/100th of 1% | ||||
| Cash flow statement | Consolidated cash flow statement | ||||
| CCAR | Comprehensive Capital Analysis and Review | ||||
| CCyB | Countercyclical capital buffer | ||||
| CDO | Collateralized debt obligation(s), including Collateralized loan obligation(s) | ||||
| CDS | Credit default swaps | ||||
| CECL | Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update | ||||
CET1 | Common Equity Tier 1 | ||||
| CFTC | U.S. Commodity Futures Trading Commission | ||||
| CLN | Credit-linked note(s) | ||||
| CLO | Collateralized loan obligation(s) | ||||
| CMBS | Commercial mortgage-backed securities | ||||
| CMO | Collateralized mortgage obligation(s) | ||||
| CRE | Commercial real estate | ||||
| CRM | Credit Risk Management Department | ||||
| CTA | Cumulative foreign currency translation adjustments | ||||
| DCP | Employee deferred cash-based compensation plans linked to investment performance | ||||
| DCP investments | Investments associated with certain DCP | ||||
| DVA | Debt valuation adjustment | ||||
| EBITDA | Earnings before interest, taxes, depreciation and amortization | ||||
| EMEA | Europe, Middle East and Africa | ||||
| EPS | Earnings per common share | ||||
| FDIC | Federal Deposit Insurance Corporation | ||||
| FFELP | Federal Family Education Loan Program | ||||
| FHC | Financial holding company | ||||
| FICO | Fair Isaac Corporation | ||||
| Financial statements | Consolidated financial statements | ||||
| FVO | Fair value option | ||||
| G-SIB | Global systemically important bank | ||||
| HFI | Held-for-investment | ||||
| HFS | Held-for-sale | ||||
| HQLA | High-quality liquid assets | ||||
| HTM | Held-to-maturity | ||||
| I/E | Intersegment eliminations | ||||
| IHC | Intermediate holding company | ||||
| IM | Investment Management | ||||
| Income statement | Consolidated income statement | ||||
| IRS | Internal Revenue Service | ||||
| IS | Institutional Securities | ||||
| LCR | Liquidity coverage ratio, as adopted by the U.S. banking agencies | ||||
| LIBOR | London Interbank Offered Rate | ||||
| LTV | Loan-to-value | ||||
| M&A | Merger, acquisition and restructuring transaction | ||||
| MSBNA | Morgan Stanley Bank, N.A. | ||||
| MS&Co. | Morgan Stanley & Co. LLC | ||||
| MSCG | Morgan Stanley Capital Group Inc. | ||||
| MSCS | Morgan Stanley Capital Services LLC | ||||
| MSEHSE | Morgan Stanley Europe Holdings SE | ||||
| MSESE | Morgan Stanley Europe SE | ||||
| MSIP | Morgan Stanley & Co. International plc | ||||
| MSMS | Morgan Stanley MUFG Securities Co., Ltd. | ||||
| MSPBNA | Morgan Stanley Private Bank, National Association | ||||
| MSSB | Morgan Stanley Smith Barney LLC | ||||
| MUFG | Mitsubishi UFJ Financial Group, Inc. | ||||
| MUMSS | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | ||||
| MWh | Megawatt hour | ||||
| N/A | Not Applicable | ||||
| N/M | Not Meaningful | ||||
| NAV | Net asset value | ||||
| Non-GAAP | Non-generally accepted accounting principles in the U.S. | ||||
| NSFR | Net stable funding ratio, as adopted by the U.S. banking agencies | ||||
| OCC | Office of the Comptroller of the Currency | ||||
| OCI | Other comprehensive income (loss) | ||||
| OTC | Over-the-counter | ||||
| PSU | Performance-based stock unit | ||||
| ROE | Return on average common equity | ||||
| ROTCE | Return on average tangible common equity | ||||
| ROU | Right-of-use | ||||
| RSU | Restricted stock unit | ||||
| RWA | Risk-weighted assets | ||||
| SCB | Stress capital buffer | ||||
| SEC | U.S. Securities and Exchange Commission | ||||
| SLR | Supplementary leverage ratio | ||||
| S&P | Standard & Poor’s | ||||
| SPE | Special purpose entity | ||||
| SPOE | Single point of entry | ||||
| TLAC | Total loss-absorbing capacity | ||||
| U.K. | United Kingdom | ||||
| UPB | Unpaid principal balance | ||||
| U.S. | United States of America | ||||
| U.S. Bank Subsidiaries | Morgan Stanley Bank N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) | ||||
| U.S. GAAP | Accounting principles generally accepted in the U.S. | ||||
| VaR | Value-at-Risk | ||||
| VIE | Variable interest entity | ||||
| WACC | Implied weighted average cost of capital | ||||
| WM | Wealth Management | ||||
73 | March 2024 Form 10-Q | |||||||
| $ in millions, except per share data | Total Number of Shares Purchased1 | Average Price Paid per Share | Total Shares Purchased as Part of Share Repurchase Authorization2,3 | Dollar Value of Remaining Authorized Repurchase | ||||||||||
| January | 8,995,283 | $ | 86.00 | 1,878,800 | $ | 17,039 | ||||||||
| February | 6,331,034 | $ | 86.05 | 5,213,800 | $ | 16,590 | ||||||||
| March | 4,536,567 | $ | 88.02 | 4,429,444 | $ | 16,200 | ||||||||
| Three Months Ended March 31, 2024 | 19,862,884 | $ | 86.48 | 11,522,044 | ||||||||||
| Exhibit No. | Description | ||||
| 15 | |||||
| 31.1 | |||||
| 31.2 | |||||
| 32.1 | |||||
| 32.2 | |||||
| 101 | Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”). | ||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). | ||||
MORGAN STANLEY (Registrant) | |||||
| By: | /s/ SHARON YESHAYA | ||||
| Sharon Yeshaya Executive Vice President and Chief Financial Officer | |||||
| By: | /s/ RAJA J. AKRAM | ||||
| Raja J. Akram Deputy Chief Financial Officer, Chief Accounting Officer and Controller | |||||
| March 2024 Form 10-Q | 74 | |||||||